Document:

Exhibit 10.31

 

Boston
Biomedica Inc. – Consultant Agreement

 

This Agreement is entered into
as of the 31st day of December, 2003, between Boston Biomedica Inc. (“the
Company”) and Richard T. Schumacher (“the Consultant”).

 

WHEREAS, the Company desires to
assure itself that the benefits of the consulting abilities and talents of the
Consultant relative to certain aspects of the Company’s business will be
available to the Company;

 

NOW, THEREFORE, in
consideration of the mutual covenants and promises herein contained, the
receipt and sufficiency of which is hereby acknowledged, and intending to be
legally bound, it is hereby agreed by and between the parties as follows:

 

1.     Consulting Engagement.  Subject to the terms and conditions of this
Agreement, the Company hereby extends the current engagement of the Consultant
as Executive Project Consultant to perform the services set forth herein, and
the Consultant hereby accepts such engagement.

 

2.     Term. 
The Term of the Consultant’s engagement hereunder shall commence on the
date hereof and extend through December 31, 2004 unless sooner terminated as
hereinafter provided.

 

3.     Duties.  Subject to the terms and conditions in this
Agreement, the Consultant’s duties as Executive Project Consultant shall be to
take an advisory role in directing the Company’s PCT and Source activities and
the Company’s ownership interest in Panacos Pharmaceuticals, Inc. (“Panacos”),
each as further described below, and such other duties as may be assigned to
him by the President of the Company or the Board from time to time.  The Consultant shall report to, be
specifically accountable to, and shall follow the directions of the  Board of Directors of the Company The
Consultant shall devote substantially all his business time and energy and will
use his best efforts to perform his duties hereunder.  The Consultant will be given reasonable access to Company
personnel to assist the Consultant in the fulfillment of his duties and
responsibilities under this Agreement.

 

4.     Compensation. 
During the term of the Consultant’s engagement under this Agreement, the
Consultant shall be paid $4,807.90 per week, which is equivalent to an
annualized salary of $250,000.00, prorated for the number of weeks between the
date hereof and December 31, 2004 and based on a 52 week year.  Such amounts shall be paid periodically in
accordance with the Company’s normal payroll practices.  The Consultant will also be eligible to
receive from the Company a performance bonus in recognition of the successful
completion of his duties and responsibilities as described herein.  The amount of such performance bonus, if
any, and the date upon which it will be paid, will be determined by the Board
of Directors of the Company in its sole and exclusive discretion.  In addition to his salary and bonus, if any,
for the sole purpose of determining compensation and benefits, the Consultant
shall be considered a full time employee and as such will be entitled to
participate in and immediately eligible for health and medical insurance, disability
insurance, group life insurance, group travel insurance, and 401(k) retirement
plan applicable to all full

 

 

time employees of the Company as they may be
in effect from time to time.  The
Consultant’s prior service with the Company shall be attributed to Consultant
in determining eligibility to participate in and the extent of benefits from
such benefit plans.  There shall be no
waiting period for participation in any such plan.  The Consultant shall be eligible for vacation, holidays and sick
days in accordance with the Company’s policies applicable to all full time
employees.

 

5.     PCT, Source and Panacos. The Consultant
shall assume an advisory role in directing the Company’s PCT and Source
Divisions and the Company’s ownership interest in Panacos.  The heads of the Company’s PCT and Source
Divisions shall report to the Consultant.

 

6.     PCT Division. In performing
his PCT duties set forth in Paragraph 5 above, until such time as the business
plan, including the operating budget, is approved by the Board, the Consultant
shall limit the monthly losses from the PCT Division to an amount equal to or
less than the average monthly amount of losses that have been incurred by the
PCT Division since January 1, 2003.  For
this purpose, however, the Consultant’s salary and related expenses will not be
considered in the calculation of PCT’s losses. 
The Consultant further understands and agrees that the President of the
Company, representing the Board, may determine based on the Company’s overall
financial condition that it may be necessary to further limit the amount of
losses incurred by the PCT Division.

 

Without
limiting the foregoing, the Consultant shall prepare a marketing plan for the
PCT Division for the Board.  The
marketing plan shall be prepared within a time period specified by the Board of
Directors.  The strategy and activities
contained in the marketing plan shall include, but not be limited to, ongoing
scientific review and attendance at scientific conferences, communication with
leading scientific investigators in the field and investigation of potential
opportunities with the United States government relating to homeland defense.

 

7.     In performing his Source Division duties as
set forth in Paragraph 5, above, but without limitation of such duties, the
Consultant shall assist in identifying potential contract procurement
opportunities for the Source Division and in identifying strategic
opportunities for the Source Division.

 

8.     Payment of the Commerce Loan. With the proceeds
(net of required taxes) Consultant may receive from the sale of any personal
assets,  the Consultant shall promptly
apply all such net proceeds to repay all amounts due to Commerce Bank &
Trust Company (“Commerce Bank”), whether owed personally or by any affiliate of
the Consultant, including Resort Accommodations International LLC (“RAI”) and
whether or not then due pursuant to the terms of any note or loan agreement
with Commerce Bank (the “Commerce Bank Loan”) and all amounts owed to the
Company by the Consultant or any such affiliate pursuant to (i) that certain
Limited Guaranty by the Company for the benefit of Commerce Bank dated January
15, 2002, (ii) that certain Junior Participation Agreement also dated January
15, 2002 by and between Commerce Bank, RAI and the Company, (iii) that certain
Pledge Agreement also dated January 15, 2002 by and between the Company and
Commerce Bank, and (iv) that certain Pledge and Security Agreement dated as of
January 15, 2002 by and between the Consultant, the Company and Commerce Bank.  By entering into this Agreement, the
Consultant hereby ratifies, confirms and

 

 

acknowledges his obligations to the Company under
such agreements referred to in clauses (i) through (iv) above (the “Company’s
Guarantee”).  Notwithstanding the
foregoing, if and to the extent the Consultant or his affiliates has funds or
assets in excess of ordinary and routine living expenses, the Consultant shall
repay the Commerce Bank Loan and the Company’s Guarantee.

 

9.     Expenses. 
During the term of this Agreement, the Consultant shall obtain prior
approval for any and all out-of-pocket expenses incurred in connection with the
performance of his duties hereunder and otherwise in accordance with the
Company’s reimbursement policy and procedure as in effect from time to time.  If approved in advance, the Consultant shall
submit invoices for such approved expenses in accordance with the Company’s
expense reimbursement procedures, and the Company shall reimburse him for all
such approved out-of-pocket expenses.

 

10.   Written Reports.  The Company may request that plans, progress reports and results
reports be provided by the Consultant on a weekly or monthly basis as requested
by the Company.  The reports shall be in
such form and setting forth such information and data as is reasonably
requested by the Company.

 

11.   Inventions. 
Any and all inventions, discoveries, developments and innovations
conceived by the Consultant during this engagement relative to the duties under
this Agreement shall be the exclusive property of the Company; and the
Consultant hereby assigns all right, title, and interest in the same to the
Company.  Any and all inventions,
discoveries, developments and innovations conceived by the Consultant prior to
his engagement hereunder and utilized by him in rendering duties to the Company
are hereby licensed to the Company for use in its operations and for an
infinite duration.  This license is
non-exclusive, and may be assigned without the Consultant’s prior written approval
by the Company to a wholly-owned subsidiary of the Company.

 

12.   Confidentiality. The Consultant acknowledges
that during his engagement hereunder, he will have access to and become
acquainted with various trade secrets, inventions, innovations, processes,
information, records and specifications owned or licensed by the Company and/or
used by the Company in connection with the operation of its business including,
without limitation, the Company’s business and product processes, methods,
customer lists, accounts and procedures. 
The Consultant agrees that he will not disclose any of the aforesaid,
directly or indirectly, or use any of them in any manner, either during his
engagement hereunder or at any time thereafter, except as required in the
course of his engagement by the Company. 
All files, records, documents, blueprints, specifications, information,
letters, notes, media lists, original artwork/creative, notebooks, and similar
items relating to the business of the Company whether prepared by the
Consultant or otherwise coming into his possession during his engagement
hereunder, shall remain the exclusive property of the Company.  The Consultant shall not retain any copies
of the foregoing without the Company’s prior written permission.  Upon the termination of his engagement
hereunder, or whenever requested by the Company, the Consultant shall
immediately deliver to the Company all such files, records, documents,
specifications, information, and other items in his possession or under his
control.

 

13.   Disclosure. 
The Consultant shall not disclose the terms of this Agreement to any
person without the prior written consent of the Company.  The Company may issue a

 

 

press release to announce the Consultant’s
continued engagement.  If the Company
determines to issue such a press release, it shall promptly submit the press
release to the Consultant for his review and approval prior to release to the
public.

 

14.   Conflicts of Interest; Non-hire Provision.  The Consultant represents that he is free to
enter into this Agreement, and that this engagement does not violate the terms
of any agreement between the Consultant and any third party.  Further, the Consultant, in rendering his
duties shall not utilize any invention, discovery, development, improvement, innovation,
or trade secret in which he does not have a proprietary interest.  If the Company is not in breach of its
obligations under this Agreement, for a period of one year following
termination of his engagement hereunder, the Consultant shall not, directly or
indirectly hire, solicit, or encourage to leave the Company’s employment, any
employee,  consultant, or contractor of
the Company or hire any such employee, 
consultant, or contractor who has left the Company’s employment or
contractual engagement within one year of such employment or engagement, (other
than such employees, consultants and contractors who have been involuntarily
terminated by the Company).

 

15.   Right to Injunction.  The parties hereto acknowledge that the
services to be rendered by the Consultant under this Agreement, the rights and
privileges granted to the Company under the Agreement, the benefits to be
received by the Consultant and the obligations of the Company hereunder are of
a special, unique, unusual, and extraordinary character which gives them a
peculiar value, the loss of which cannot be reasonably or adequately
compensated by damages in any action at law, and the breach by either party of
any of the provisions of this Agreement will cause the other irreparable injury
and damage.  The parties expressly agree
that each party shall be entitled to injunctive and other equitable relief in
the event of, or to prevent, a breach of any provision of this Agreement by
the  other party.  Resort to such equitable relief, however,
shall not be construed to be a waiver of any other rights or remedies that such
party may have for damages or otherwise. 
The various rights and remedies of the 
parties under this Agreement or otherwise shall be construed to be
cumulative, and no one of the them shall be exclusive of any other or of any
right or remedy allowed by law.

 

16.   Termination.  The Consultant’s engagement hereunder may be
terminated prior to December 31, 2004 as follows:

 

(i)            With Cause.  The Board may terminate the Consultant’s
engagement hereunder at any time and without further obligation for cause.  If the Board terminates the engagement for
cause, then it shall only owe the Consultant compensation that has accrued and
has not yet been paid as of the date of termination (calculated on a daily
basis).  For purposes of this Agreement,
“cause” shall mean the occurrence of any of the following events:

 

(A)          any material act of personal dishonesty, or
serious misconduct in connection with the Consultant’s responsibilities to the
Company under this Agreement;

 

 

(B)           the commission by the Consultant of any
crime classified as a felony under any Federal, state or local law or the
Consultant engaging in any acts of moral turpitude;

 

(C)           continued material violations, breach or
noncompliance by the Consultant of the Consultant’s obligations or covenants
under this Agreement after there has been delivered to the Consultant a written
demand for performance or compliance from the Company which describes the basis
for the Company’s belief that the Consultant has violated, breached or failed
to comply with the Consultant’s duties or complied with the Consultant’s
obligations or covenants under this Agreement and such violations, breach or
noncompliance have not been corrected or cured by the Consultant within ten
(10) business days following such demand;

 

(D)          continued failure or refusal to comply with
the written policies or reasonable directives of the Company after there has
been delivered to the Consultant a written demand for performance or compliance
from the Company which describes the basis for the Company’s belief that the
Consultant has failed or refused to comply with such policies or directives and
such failure or refusal have not been corrected or cured by the Consultant
within ten (10) business days following such demand; or

 

(E)           the use by the Consultant of a controlled
substance without a prescription or the abuse of alcohol which in any way
impairs the Consultant’s ability to carry out Consultant’s duties and
responsibilities under this Agreement.

 

17.   Termination of Duties, Responsibilities and
Authority.  Although the
Consultant’s engagement hereunder shall continue through December 31, 2004, the Board may
reduce, limit or terminate part or all of the Consultant’s duties,
responsibilities and authority to provide any services under this Agreement at
any time without cause, provided however, that if the Board reduces, limits or
terminates part or all of such duties, responsibilities and authority without
cause prior to December 31, 2004, it shall continue to pay the Consultant all
of the compensation, including benefits, which otherwise would have been paid
through December 31, 2004 had the Board not so terminated such duties,
responsibilities and authority.  In such
event, the Consultant shall continue to be referred to as the Company’s
Executive Project Consultant.

 

18.   Taxes. 
The Company shall withhold taxes with respect to the Consultant’s
compensation hereunder.

 

19.   Release. 
In consideration of the Company engaging the Consultant as a consultant
hereunder, and for other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the Consultant hereby releases,
remises, and

 

 

forever discharges the Company and the
Company’s officers, directors and affiliates from all debts, demands, actions,
causes of actions, suits, accounts, covenants, contracts, agreements, damages,
and all claims and liabilities of every nature, which the Consultant or the
Consultant’s successors or assigns now have or ever had against the Company or
its officers, directors and affiliates, jointly, severally, or individually.

 

20.   Successors and Assigns.  All of the provisions of this Agreement
shall be binding upon and inure to the benefit of the parties hereto and their
respective heirs, if any, successors, and assigns, provided, however, the
Consultant shall not assign any of his rights under this Agreement, or delegate
the performance of any of his duties hereunder, without the prior written
consent of the Company.

 

21.   Choice of Law.  The laws of the Commonwealth of Massachusetts shall govern the
validity of this Agreement, the construction of its terms and the
interpretation of the rights and duties of the parties hereto.

 

22.   Arbitration. Any controversies arising out of
the terms of this Agreement or its interpretation shall be settled in
Massachusetts in accordance with the rules of the American Arbitration
Association, and the judgment upon award may be entered in any court having
jurisdiction thereof.

 

23.   Headings. 
Section headings are not to be considered a part of this Agreement and
are not intended to be a full and accurate description of the contents hereof.

 

24.   Waiver. 
No failure or delay by either part in exercising any right under this
Agreement will operate as a waiver of such right or any other right under this
Agreement. Waiver by one party hereto of breach of any provision of this
Agreement by the other shall not operate or be construed as a continuing
waiver.

 

25.   Notices. 
Any and all notices, demands, or other communications required or desired
to be given hereunder by any party shall be in writing and shall be validly
given or made to another party if personally served, or if deposited  in the United States mail, certified or
registered, postage prepaid, return receipt requested.  If such notice or demand is served
personally, notice shall be deemed constructively made at the time of such
personal service.  If such notice,
demand or other communication is given by mail, such notice shall be
conclusively deemed given five days after deposit thereof in the United States
mail addressed to the party to whom such notice, demand or other communication
is to be given as follows:

 

If to the Consultant:

 

Richard T. Schumacher

65 Black Pond Lane

Taunton, MA 02780

 

If to the Company:

 

Boston Biomedica, Inc.

375 West Street

West Bridgewater, MA 02379

 

 

Attn:  Chairman of the Board

 

Any party hereto may change its address for purposes of this
paragraph by written notice given in the manner provided above.

 

26.   Modification or Amendment.  No amendment, change or modification of this
Agreement shall be valid unless in writing signed by the parties hereto.

 

27.   Entire Understanding.  This document and any exhibit attached
constitute the entire understanding and agreement of the parties, and any and
all prior agreements, understandings, and representations whether written or
oral are hereby terminated and canceled in their entirety and are of no further
force and effect.

 

28.   Unenforceability of Provisions.  If any provision of this Agreement, or any
portion thereof, is held to be invalid and unenforceable, then the remainder of
this Agreement shall nevertheless remain in full force and effect.

 

29.   Counterparts.  This Agreement may be executed in multiple
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

 

30.   Captions.  Captions
have been inserted solely for the convenience of reference and in no way
define, limit or describe the scope or substance of any provisions of this
Agreement.

 

IN WITNESS WHEREOF the undersigned have executed this
Agreement as of the day and year first written above.  The parties hereto agree that facsimile signatures shall be as
effective as if originals.

 

	
  Boston
  Biomedica Inc.

  	
   

  	
  Consultant:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/ Richard
  T. Schumacher

  	
   

  
	
  By:

  	
  /s/ R. Wayne
  Fritzsche

  	
   

  	
  Richard T.
  Schumacher

  
	
   

  	
  Its:
  Chairman of the BoardExhibit 10.32

 

	
  AWARD/CONTRACT

  	
   

  	
  1.  THIS CONTRACT IS A RATED ORDER UNDER DPAS (15 CFR
  350)

  	
   

  	
  RATING

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  2.  CONTRACT (Proc. Inst Ident.) NO.

  	
   

  	
  3.  EFFECTIVE DATE

  	
  4.  REQUISITION PURCHASE REQUEST/PROJECT NO.

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  N02-CP-11001

  	
   

  	
  06/01/2001

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  5.  ISSUED BY

  	
  CODE

  	
  261011001

  	
  6.  ADMINISTERED BY (If other than item 5)

  	
  CODE

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  National Cancer Institute

  	
  OD

  	
   

  
	
  Research Contracts Branch, ESS

  	
  Office of Director

  	
   

  
	
  Executive Plaza South, Room 620

  	
  Division of Epidemiology and Genetics

  	
   

  
	
  9000 Rockville Pike MSC 7224

  	
  (RFP No. N02CP11001-66)

  	
   

  
	
  Bethesda Maryland 20892-7224

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  7.  NAME AND ADDRESS OF THE CONTRACTOR (No., street,
  city, county, State and ZIP Code)

  	
   

  	
  8.  DELIVERY

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
  ý FOB Destination

  	
  o FOB Origin

  
	
  BBI Biotech
  Research Laboratories

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  217 Perry Parkway

  	
   

  	
   

  	
   

  	
   

  	
  9.  DISCOUNT FOR PROMPT PAYMENT

  
	
  Gaithersburg,
  Maryland 20877

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
  10. SUBMIT INVOICES

  	
   

  	
  ITEM

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
  (a copies unless otherwise specified)

  	
   

  	
   

  
	
  PLACE OF PERFORMANCE: Frederick, Maryland

  	
   

  	
   

  	
  TO THE ADDRESS SHOWN IN

  	
   

  	
  SEE SECTION G

  
	
  CODE

  	
   

  	
  FACILITY
  CODE

  	
   

  	
   

  	
  u

  	
   

  	
  ARTICLE G. 4.

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  11. SHIP TO/MARK FOR

  	
   

  	
  CODE

  	
  12. PAYMENT WILL BE MADE BY

  	
  CODE

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  SEE SECTION F, ARTICLE F.1.

  	
   

  	
   

  	
  SEE SECTION G, ARTICLE G.4.

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  13. AUTHORITY FOR USING OTHER THAN FULL AND OPEN
  COMPETITION

  	
  14. ACCOUNTING AND APPROPRIATION DATA

  
	
   

  	
   

  	
   

  	
  CAN1

  	
   

  	
  18332860

  	
  TIN

  	
   

  	
  043152484

  
	
  10.U.S.C. 2304(c) (   )            ?1 U.S.C. 253(c)
  (   )

  	
  CAN2

  	
   

  	
   

  	
  DOC NO.

  	
   

  	
  N2CP11001A

  
	
   

  	
   

  	
   

  	
  OC CODE

  	
   

  	
  25.2E

  	
  LOC

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  15A. ITEM
  NO.

  	
  15B
  SUPPLIES/SERVICES

  	
  15C. QUANTITY

  	
  15D. UNIT

  	
  15E. UNIT PRICE

  	
  15F. AMOUNT

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  TITLE:

  	
  Laboratory Support for Processing and
  Storage of Biological Specimens for Persons at High Risk of Cancer

  	
  CAN1:

  	
  $

  	
  1,500,000

  
	
   

  	
  CAN2:

  	
  $

  	
   

  
	
  CURRENT OBLIGATION:

  	
   

  	
  $

  	
  1,500,000

  
	
  CONTRACT PERIOD:

  	
   

  	
   

  
	
  CONTRACT TYPE:

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
  06/01/2001 through 05/31/2006

  	
   

  	
   

  	
  $

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
  Cost-Plus-Fixed Fee, COMPLETION,
  Work Assignments

  	
  $

  
	
   

  	
   

  	
  15G. TOTAL AMOUNT OF CONTRACT

  	
  $

  	
  10,326,558

  
																												

 

16. TABLE OF CONTENTS

 

	
  (X)

  	
   

  	
  SEC.

  	
   

  	
  DESCRIPTION

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  PART I - THE SCHEDULE

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  X

  	
   

  	
  A

  	
   

  	
  SOLICITATION/CONTRACT
  FORM

  	
   

  
	
  X

  	
   

  	
  B

  	
   

  	
  SUPPLIES OF
  SERVICES AND PRICES/COSTS

  	
   

  
	
  X

  	
   

  	
  C

  	
   

  	
  DESCRIPTION/SPECS/WORK
  STATEMENT

  	
   

  
	
  X

  	
   

  	
  D

  	
   

  	
  PACKAGING
  AND MARKING

  	
   

  
	
  X

  	
   

  	
  E

  	
   

  	
  INSPECTION
  AND ACCEPTANCE

  	
   

  
	
  X

  	
   

  	
  F

  	
   

  	
  DELIVERIES
  OR PERFORMANCE

  	
   

  
	
  X

  	
   

  	
  G

  	
   

  	
  CONTRACT
  ADMINISTRATION DATA

  	
   

  
	
  X

  	
   

  	
  H

  	
   

  	
  SPECIAL
  CONTRACT REQUIREMENTS

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  PART II - CONTRACT CLAUSES

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  X

  	
   

  	
  I

  	
   

  	
  CONTRACT
  CLAUSES

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  PART III - LIST OF DOCMENTS, EXHIBITS AND OTHER ATTACH

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  X

  	
   

  	
  J

  	
   

  	
  LIST OF
  ATTACHMENTS

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  PART IV - REPRESENTATIONS AND INSTRUCTIONS

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  X

  	
   

  	
  K

  	
   

  	
  REPRESENTATIONS,
  CERTIFICATIONS AND OTHER STATEMENTS OF OFFERORS

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  L

  	
   

  	
  INSTRS..
  CONDS.. AND NOTICES TO OFFERORS

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  M

  	
   

  	
  EVALUATION
  FOR AWARD

  	
   

  

 

CONTRACTING OFFICER WILL COMPLETE ITEM 17 OR
18 AS APPLICABLE

 

	
  17.  ý  CONTRACTORS NEGOTIATED AGREEMENT
  (Contractor is required to sign this document and return 1 copies to issuing
  office.) Contractor agrees to furnish and deliver all items or perform all
  the services set forth or otherwise identified above and on any continuation
  sheets for the consideration stated herein. The rights and obligations of the
  parties to this contract shall be subject to and governed by the following
  documents: (a) this award/contract, (b) the solicitation, if any, and (c)
  such provisions, representations, certifications, and specifications, as are
  attached or incorporated by reference herein. (Attachments are listed
  herein.)

  	
   

  	
  18. o
  AWARD (Contractor is not required to sign this document.) Your offer on
  Solicitation Number
                                           including
  the additions or changes made by you which additions or changes are set forth
  in full above, is herein accepted as to the items listed above and on any
  continuation  sheets. This award
  consummates the contract which consists of the following documents: (a) the
  Government’s solicitation and your offer and (b) this award/contract. No
  further contractual document is necessary.

  
	
   

  	
   

  	
   

  
	
  19A. NAME
  AND TITLE OF SIGNER (Type or print)

  	
   

  	
  20A. NAME OF
  CONTRACTING OFFICER

  
	
  Mark Manak, General Manager

  	
   

  	
  SHARON A. MILLER

  
	
   

  	
   

  	
   

  
	
  19B. NAME OF
  CONTRACTOR

  	
  19C. DATE
  SIGNED

  	
   

  	
  20B. UNITED
  STATES OF AMERICA

  	
  20C. DATE
  SIGNED

  
	
  BY

  	
  /s/ Mark
  Manak

  	
   

  	
  May 8, 2001

  	
   

  	
  BY

  	
  /s/ Sharon
  A. Miller

  	
   

  	
  6-1-01

  
	
   

  	
  (Signature
  of person authorized to sign)

  	
   

  	
   

  	
   

  	
   

  	
  (Signature
  of Contracting officer)

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  NSN
  [ILLEGIBLE]

  	
  26-107

  	
  STANDARD
  FORM 26 (REV 4-85)

  
	
  PREVIOUS
  EDITION UNUSABLE

  	
  •GPO [ILLEGIBLE]

  	
  Prescribed
  by GSA

  
	
   

  	
   

  	
  [ILLEGIBLE]

  
											

 

 

DETAILED TABLE OF CONTRACT CONTENTS

 

	
  PART 1 - THE SCHEDULE

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  SECTION A -
  SOLICITATION/CONTRACT FORM

  	
   

  
	
   

  	
   

  	
   

  
	
  SECTION B - SUPPLIES OR SERVICES AND
  PRICES/COSTS

  	
   

  
	
  ARTICLE B.1.  BRIEF DESCRIPTION OF SUPPLIES OR SERVICES

  	
   

  
	
  ARTICLE B.2.  ESTIMATED COST AND FIXED FEE

  	
   

  
	
  ARTICLE B.3.  PROVISIONS APPLICABLE TO DIRECT COSTS

  	
   

  
	
  ARTICLE B.4.  ADVANCE UNDERSTANDINGS

  	
   

  
	
  SECTION C -
  DESCRIPTION/SPECIFICATIONS/WORK STATEMENT

  	
   

  
	
  ARTICLE C.1.  STATEMENT OF WORK

  	
   

  
	
  ARTICLE C.2.  REPORTING REQUIREMENTS

  	
   

  
	
  SECTION D - PACKAGING, MARKING AND
  SHIPPING

  	
   

  
	
  ARTICLE D.1.  PACKAGING

  	
   

  
	
  ARTICLE D.2.  MARKING

  	
   

  
	
  ARTICLE D.3.  SHIPPING

  	
   

  
	
  SECTION E - INSPECTION AND ACCEPTANCE

  	
   

  
	
  SECTION F - DELIVERIES OR PERFORMANCE

  	
   

  
	
  ARTICLE F. 1.  DELIVERIES

  	
   

  
	
  ARTICLE F.2.  CLAUSES INCORPORATED BY REFERENCE

  	
   

  
	
  SECTION G - CONTRACT ADMINISTRATION
  DATA

  	
   

  
	
  ARTICLE G.1.  PROJECT OFFICER

  	
   

  
	
  ARTICLE G.2.  KEY
  PERSONNEL

  	
   

  
	
  ARTICLE G.3.  WORK ASSIGNMENT PROCEDURES

  	
   

  
	
  ARTICLE G.4.  INVOICE SUBMISSION/CONTRACT FINANCING REQUEST

  	
   

  
	
  ARTICLE G.5.  CONTRACT FINANCIAL REPORT

  	
   

  
	
  ARTICLE G.6.  INDIRECT COST RATES

  	
   

  
	
  ARTICLE G.7.  GOVERNMENT PROPERTY

  	
   

  
	
  ARTICLE G.8.  POST AWARD EVALUATION OF CONTRACTOR PERFORMANCE

  	
   

  
	
  SECTION H - SPECIAL CONTRACT REQUIREMENTS

  	
   

  
	
  ARTICLE H.1.  REIMBURSEMENT OF COSTS FOR INDEPENDENT RESEARCH AND DEVELOPMENT
  PROJECTS

  	
   

  
	
  ARTICLE H.2.  HUMAN SUBJECTS

  	
   

  
	
  ARTICLE H.3.  HUMAN
  MATERIALS

  	
   

  
	
  ARTICLE H.4.  NEEDLE EXCHANGE

  	
   

  
	
  ARTICLE H.5.  PRIVACY ACT

  	
   

  
	
  ARTICLE H.6.  CONFIDENTIALITY OF INFORMATION

  	
   

  
	
  ARTICLE H.7.  PUBLICATION AND PUBLICITY

  	
   

  
	
  ARTICLE H.8.  PRESS
  RELEASES

  	
   

  
	
  ARTICLE H.9.  REPORTING MATTERS INVOLVING FRAUD, WASTE AND ABUSE

  	
   

  
	
   

  	
   

  	
   

  
	
  PART II - CONTRACT CLAUSES

  	
   

  
	
  SECTION I - CONTRACT CLAUSES

  	
   

  
	
  ARTICLE I.1.  GENERAL CLAUSES FOR A COST-REIMBURSEMENT SERVICE CONTRACT

  	
   

  
	
  ARTICLE I.2   AUTHORIZED SUBSTITUTION OF CLAUSES

  	
   

  
	
  ARTICLE I.3.  ADDITIONAL CONTRACT CLAUSES

  	
   

  
	
  ARTICLE I.4.  ADDITIONAL FAR CONTRACT CLAUSES INCLUDED IN FULL TEXT

  	
   

  
	
   

  	
   

  
	
  PART
  III

  	
   

  	
   

  
	
  SECTION J - LIST OF ATTACHMENTS

  	
   

  
	
  1.

  	
  Statement of Work

  	
   

  
					

 

2

 

	
  2.

  	
  Sample Contract Work Assignment

  	
   

  
	
  3.

  	
  Invoice/Financing Request Instructions for
  NIH Cost Reimbursement Type Contracts

  	
   

  
	
  4.

  	
  Financial Report of Individual
  Project/Contract

  	
   

  
	
  5.

  	
  Instructions
  for Completing form NIH 2706. Financial Report of Individual Project/Contract

  	
   

  
	
  6.

  	
  Privacy
  Act System of Records

  	
   

  
	
  7.

  	
  Safety
  and Health

  	
   

  
	
  8.

  	
  Procurement
  of Certain Equipment

  	
   

  
	
  9.

  	
  Government Property - Schedule I-B

  	
   

  
	
  10.

  	
  Government Property - Schedule II-A

  	
   

  
	
  11.

  	
  Report of Government Owned, Contractor Held
  Property

  	
   

  
	
   

  	
   

  	
   

  
	
  PART IV

  	
   

  	
   

  
	
  SECTION K - REPRESENTATIONS AND
  CERTIFICATIONS

  	
   

  
	
  1.

  	
  Representations and Certifications

  	
   

  

 

3

 

 

SECTION B
- SUPPLIES OR SERVICES AND PRICES/COSTS

 

ARTICLE B.1. BRIEF DESCRIPTION OF
SUPPLIES OR SERVICES

 

The objective of this acquisition are to support molecular epidemiology
projects undertaken by the Division of Cancer Epidemiology and Genetics.
National Cancer Institute. These technical services shall include:

 

•              Accessioning and
processing biological specimens for molecular epidemiology studies

•              Organizing,
aliquoting and dispersing samples to DCEG collaborators

•              Maintaining the
existing blorepository and expanding it as necessary

•              Maintaining accurate
information on the quality, quantity and location of samples, and to provide
these data in a timely manner for the computerized sample inventory

•              Exploring new or
improved methods to achieve the above objectives in a more cost-efficient
manner

•              Conducting method
studies as required to resolve issues of direct relevance to specimen
processing or storage

•              Evaluating and
piloting new technologies germane to the contract mission

•              Maintaining
appropriate quality assurance systems for the biorepository and bioprocessing
laboratories.

 

ARTICLE B.2.
ESTIMATED COST AND FIXED FEE

 

a.             The estimated cost of this contract is
$9,811,557.

 

b.             The fixed fee for this contract is
$515,001. The fixed fee shall be paid in installments based on the percentage
of completion of work, as determined by the Contracting Officer, and subject to
the withholding provisions of the clauses ALLOWABLE COST AND PAYMENT and FIXED
FEE referenced in the General Clause Listing in Part II, ARTICLE I.1. of
this contract. Payment of fixed fee shall not be made in less than monthly
increments.

 

c.             The Government’s obligation, represented
by the sum of the estimated cost plus fixed fee, is $10,326,558.

 

d.             Total funds currently available for
payment and allotted to this contract are $1,500,000 of which $1,426,262
represents the estimated costs, and of which $73,738 represents the fixed fee.
For further provisions on funding, see the LIMITATION OF FUNDS clause
referenced in Part II, ARTICLE I.2. Authorized Substitutions of Clauses.

 

e.             It is estimated that the amount currently
allotted will cover performance of the contract through February 28, 2002.

 

f.              The Contracting Officer may allot
additional funds to the contract without the concurrence of the Contractor.

 

ARTICLE B.3. PROVISIONS APPLICABLE TO
DIRECT COSTS

 

a.             Items Unallowable
Unless Otherwise Provided

 

Notwithstanding the clauses, ALLOWABLE COST AND PAYMENT, and FIXED FEE,
incorporated in this contract, unless authorized in writing by the Contracting
Officer, the costs of the following items or activities shall be unallowable as
direct costs:

 

(1)           Acquisition, by purchase or less, of any
interest in real property;

 

(2)           Special rearrangement or alteration of
facilities;

 

(3)           Purchase or lease of any item of general
purpose office furniture or office equipment regardless of dollar value.
(General purpose equipment is defined as any items of personal property which
are usable for purposes other than

 

4

 

research, such as office equipment and furnishings, pocket calculators,
etc.);

 

(4)           Travel to attend general scientific
meetings;

 

(5)           Foreign travel - See b (2) below:

 

(6)           Consultant costs

 

(7)           Subcontracts;

 

(8)           Patient care costs;

 

(9)           Accountable Government property (defined as
both real and personal property with an acquisition cost of $1,000 or more and
a life expectancy of more than two years) 
and “sensitive items” (defined and listed in the Contractor’s Guide for
Control of Government Property), 1990, regardless acquisition value.

 

b.             Travel Costs

 

(1)           Domestic Travel

 

(a)           Total expenditures for domestic travel
(transportation, lodging, subsistence, and incidental expenses) incurred in
direct performance of this contract shall not exceed $4,885 without the prior
written approval of the Contracting Officer.

 

(b)           The Contractor shall invoice and be
reimbursed for all travel costs in accordance with Federal Acquisition
Regulations (FAR) 31.205-46.

 

(2)           Foreign Travel

 

Requests for foreign travel must be submitted at least six weeks in
advance and shall contain the following: (a) meeting(s) and place(s) to be
visited, with costs and dates; (b) name(s) and title(s) of Contractor personnel
to travel and their functions in the contract project; (c) contract purposes to
be served by the travel; (d) how travel of contractor personnel will benefit
and contribute to accomplishing the contract project, or will otherwise justify
the expenditure of NIH contract funds; (e) how such advantages justify the
costs for travel and absence from the project of more than one person if such
are suggested; and (f) what additional functions may be performed by the
travelers to accomplish other purposes of the contract and thus further benefit
the project.

 

ARTICLE B.4.
ADVANCE UNDERSTANDINGS

 

Other provisions of this contract notwithstanding, approval of the
following items within the limits set forth is hereby granted without further
authorization from the Contracting Officer.

 

a.             Total expenditures for moving freezers to
5107 Pegasus Court, Frederick, MD from 217 Perry Parkway, Gaithersburg, MD
incurred in direct performance of this contract shall not exceed $83,040
without prior written approval of the Contracting Officer.

 

b.             The government’s obligation under this
contract is the total dollars authorized by the work assignments issued under
the contract.

 

5

 

SECTION C -
DESCRIPTION/SPECIFICATIONS/WORK STATEMENT

 

ARTICLE C.1. STATEMENT OF WORK

 

a.             Independently and not as an agent of the
Government, the Contractor shall furnish all the necessary services, qualified
personnel, material, equipment, and facilities, not otherwise provided by the
Government as needed to perform the Statement of Work, SECTION J,
ATTACHMENT I, dated August 2000, attached hereto and made a part of this
contract.

 

ARTICLE C.2.
REPORTING REQUIREMENTS

 

a.             Technical Reports

 

In addition to
those reports required by the other terms of this contract, the Contractor
shall prepare and submit the following reports in the manner stated below and
in accordance with ARTICLE F.1. DELIVERIES of this contract:

 

(1)           Quarterly
Computerized and Written Reports

 

The Contractor
shall submit Quarterly Computerized and Written Reports summarizing the status
of all newly received specimens and outlining all dispersals by the laboratory.
The information should by tracked by project code and submitted with the
quarterly report. A summary of all correspondence consisting of requests for
shipment, cover letters and inquiries from outside collaborators shall be
submitted quarterly to the NCI Project Officer and made available upon request.
Emphasis shall be on conciseness as well as comprehensiveness.

 

The first quarterly report shall cover the period consisting of the
first full calendar quarter following the effective date of the contract and
shall be due on or before September 15, 2001. Thereafter, reports shall be
due on or before the 15th day of the month following each quarterly
reporting period. A Quarterly Computerized and Written Report shall not be
required when submitting the Annual Reports or Final Report.

 

(2)           Annual
Technical Progress Report

 

The Contractor shall prepare Annual Technical Progress Reports which
explain the progress of work performed under this contract. Each report shall
describe the progress of the project to date, nothing all technical areas in
which effort is being directed and indicating the status of work in each area.
This report shall include:

 

a)             A quantitative summary of the number of
specimens processed by the Contractor, their type and investigator source;

 

b)            Shipments and logistics;

 

c)             An indication of current problems that may
impede performance under the contract and proposed corrective action; and

 

e)             A
summary of work assignments issued to date, general progress on each work
assignment, and the estimated and actual cost to date on each assignment.

 

d)            A discussion of work to be performed during
the next reporting period.

 

The annual report
shall, in addition, include the information described in item #9 of the
statement of work. Additional interim reports may be requested as necessary.

 

The first annual report shall cover the period consisting of the first
full calendar year following the effective date of

 

6

 

the contract and shall be due on or before July 1, 2002. Emphasis
shall be on conciseness as well as comprehensiveness. A separate annual
technical progress report shall not be required when submitting the Final
Report.

 

(3)           Final
Technical Progress Report

 

The Contractor shall submit a final technical progress report on or
before the expiration date of the contract. The Final Report shall include
information in sufficient detail to describe comprehensively the results
achieved and shall include a summation of the work performed for the entire
period of performance.

 

SECTION D - PACKAGING,
MARKING AND SHIPPING

 

ARTICLE D.1. PACKAGING

 

Specimens shall be protected from temperature extremes by use of
insulated containers or other acceptable means as needed. Portable liquid
nitrogen containers for transport of frozen cells shall also be required.

 

ARTICLE D.2. MARKING

 

All deliverable under this contract shall be clearly identified with
the subject contract number. All specimens shall be submitted to the
Contractor, accompanied by written identification of the specimen source, using
forms supplied by the Project Officer. All specimens will be submitted to the
Contractor with a unique alpha-numeric code number which will be the only
identification of the specimen in future laboratory processing, dispersal, etc.
The name of the donor shall not be used in the labeling of specimens by
laboratory personnel. No names of persons
enrolled in AIDS-associated studies shall be written on vials.

 

ARTICLE D.3. SHIPPING

 

The Contractor shall prepare specimens for shipment, supply shipping
containers appropriate to maintain specimens in the proper state (cool, frozen,
deep frozen, etc.) and make arrangements through commercial air freight
companies and other carriers to send biologic specimens to collaborating
investigators in an expeditious (e.g. overnight or same day) fashion. For
immunologic or genetic typing studies, for example, the Contractor shall
prepare specimens for delivery to the local Human Leukocyte Antigen (HLA)
typing laboratory or immune function laboratory in a suitable form. The local
in-house delivery service shall be used for these particular specimens to
ensure expeditious delivery under optimum conditions. In some cases, commercial
freight companies shall be used for overnight shipments to investigators in
other cities. The Contractor shall be responsible for notifying the receiving
laboratory of the specimens shipment and anticipated arrival time to insure
that the receiving laboratory is prepared to receive the specimens.

 

SECTION E - INSPECTION AND ACCEPTANCE

 

a.             The Contracting Officer or the duly
authorized representative will perform inspection and acceptance of materials
and services to be provided.

 

b.             For the purpose of this SECTION, the
Project Officer identified in ARTICLE G 1 is the authorized representative
of the Contracting Officer.

 

c.             Inspection and acceptance will be
performed at the National Cancer Institute, 6120 Executive Boulevard. Room
7020. Bethesda. MD 20892.

 

Acceptance may be
presumed unless otherwise indicated in writing by the Contracting Officer or
the duly authorized 

 

7

 

representative
within 60 days of receipt.

 

d.             This contract incorporates the following
clause by reference, with the same force and effect as if it were given in full
text. Upon request, the Contracting Officer will make its full text available.

 

FAR Clause No.
52.246-5, INSPECTION OF SERVICES-COST REIMBURSEMENT (APRIL 1984).

 

SECTION F - DELIVERIES OR PERFORMANCE

 

ARTICLE F.1. DELIVERIES

 

Satisfactory performance of the final contract shall be deemed to occur
upon performance of the work described in Article C.1. and upon delivery
and acceptance by the Contracting Officer, or the duly authorized
representative, of the following items in accordance with the stated delivery
schedule:

 

a.             The items specified below as described in
SECTION C, ARTICLE C.2. will be required to be delivered F.O.B.
Destination as ser forth in FAR 52.247-35, F.O.B. DESTINATION, WITHIN
CONSIGNEES PREMISES (APRIL 1984), and in accordance with and by the dates
specified below and any specifications stated in SECTION D, PACKAGING,
MARKING AND SHIPPING, of the contract:

 

	
  Item

  	
   

  	
  Description

  	
   

  	
  Quantity

  	
   

  	
  Delivery
  Schedule

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  (1)

  	
   

  	
  Quarterly Computerized and Written Reports

  	
   

  	
  3

  	
   

  	
  First report due 09/15/01; all others due on the 15th day
  of the month following each Quarterly reporting period.

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  (2)

  	
   

  	
  Annual Technical Progress Report

  	
   

  	
  3

  	
   

  	
  July 1, 2002

  July 1, 2003

  July 1, 2004

  July 1, 2005

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  (3)

  	
   

  	
  Final Technical Progress Report

  	
   

  	
  3

  	
   

  	
  On or before May 31, 2006

  

 

b.             The
above items (1) through (3) shall be addressed and delivered to:

 

	
  Original:

  	
   

  	
  Contracting Officer

  
	
   

  	
   

  	
  Epidemiology and Support Section

  
	
   

  	
   

  	
  Research Contract Branch, OD

  
	
   

  	
   

  	
  National Cancer Institute

  
	
   

  	
   

  	
  Executive Plaza South, Room 620

  
	
   

  	
   

  	
  6120 EXECUTIVE BLVD MSC 7224

  
	
   

  	
   

  	
  BETHESDA, MD 20892-7224

  
	
   

  	
   

  	
   

  
	
  Copies:

  	
   

  	
  Project Officer

  
	
   

  	
   

  	
  Office of the Director

  
	
   

  	
   

  	
  Division of Cancer Epidemiology & Genetics

  
	
   

  	
   

  	
  Executive Plaza South, Room 7020

  
	
   

  	
   

  	
  6120 EXECUTIVE BLVD MSC 7242

  
	
   

  	
   

  	
  BETHESDA, MD 20892-7242

  

 

8

 

ARTICLE F.2.
CLAUSES INCORPORATED BY REFERENCE, FAR 52.252-2 (FEBRUARY 1998)

 

This contract incorporates the following clause by reference, with the
same force and effect as if it were given in full text. Upon request, the
Contracting Officer will make its full text available. Also, the full text of a
clause may be accessed electronically at this address:
http://www.arnet.gov/far/.

 

FEDERAL ACQUISITION REGULATION (48 CFR CHAPTER 1) CLAUSE:

 

52.242-15. Stop Work Order (AUGUST 1989) with ALTERNATE
(APRIL 1984).

 

SECTION G - CONTRACT ADMINISTRATION DATA

 

ARTICLE G.1. PROJECT OFFICER

 

The following Project Officer and Assistant Officers will represent the
Government for the purpose of this contract:

 

	
  Dr. Jim Vaught, Project Officer

  
	
   

  	
   

  	
   

  
	
  Assistant Project Officers:

  	
   

  	
  Dr. Dalsu Baris

  
	
   

  	
   

  	
  Dr. Mark Green

  
	
   

  	
   

  	
  Dr. Rashmi Sinha

  
	
   

  	
   

  	
  Dr. Mark Schiffman

  
	
   

  	
   

  	
  Dr. Charles Rabkin

  
	
   

  	
   

  	
  Dr. Neil Caporaso

  

 

The Project Officer is responsible for: (1) monitoring the Contractor’s
technical progress, including the surveillance and assessment of performance
and recommending to the Contracting Officer changes in requirements; (2)
interpreting the Statement of Work and any other technical performance
requirements; (3) performing technical evaluation as required; (4) performing
technical inspections and acceptances required by this contract; and (5)
assisting in the resolution of technical problems encountered during
performance.

 

The Assistant Project Officer’s will be responsible for coordinating
the requirements of their individual DCEG Branch.  Assistant Project Officer’s will not be allowed to initiate Work
Assignments for contract support or to modify ongoing contract tasks without
discussing with the Project Officer.

 

The Contracting Officer is the only person with authority to act as
agent of the Government under this contract. Only the Contracting Officer has
authority to: (1) direct or negotiate any changes in the Statement of Work; (2)
modify or extend the period of performance; (3) change the delivery schedule;
(4) authorize reimbursement to the Contractor any costs incurred during the
performance of this contract; or (5) otherwise change any terms and conditions
of this contract.

 

The Government may unilaterally change its Project Officer designation.

 

ARTICLE G.2. KEY PERSONNEL

 

Pursuant to the Key Personnel clause incorporated in this contract, the
following individuals are considered to be essential to the work being
performed hereunder:

 

9

 

	
  Name

  	
   

  	
  Title

  
	
   

  	
   

  	
   

  
	
  Mark Cosentino

  	
   

  	
  Principal Investigator

  
	
  Jay Ji

  	
   

  	
  Assistant Investigator

  
	
  Andy Slywester

  	
   

  	
  Assistant Investigator

  
	
  Kathi Shea

  	
   

  	
  Assistant Investigator

  
	
  Caria Hanson

  	
   

  	
  Project Manager

  

 

ARTICLE G.3. WORK ASSIGNMENT PROCEDURES

 

In providing support under this contract, the Contractor shall initiate
work only when so directed by a Work Assignment (Attachment provided in
SECTION J). Approval of a Work Assignment shall not constitute approval to
exceed any item listed in the contract or general clauses of the contract. Work
Assignment amounts shall not exceed the total amounts listed in the contract
(time, dollars, consultants, travel, etc.). The Project Officer with
Contracting Officer approval, is authorized to initiate Work Assignments and to
sign Work Assignments indicating satisfactory performance/delivery of the
services/product required in each work Assignment. The Contractor shall assure,
prior to commencing work on any Work Assignment, that written approval of the
Project Officer and the Contracting Officer has been obtained. A Work
Assignment which does not contain both Contracting Officer and Project Officer
approval signatures shall be considered invalid and costs incurred for such
work shall be considered unallowable. The Contractor shall not exceed the
estimated Work Assignment amount, or change the Work Assignment leader without
prior written approval of the Project Officer and the Contracting Officer by
modification of the Work Assignment. The day-to-day operational and
administrative details of the Work Assignment system will be established by the
Project Officer with input from the Contractor. The work assignment system will
operate within the following general guidelines:

 

a.             Work Assignment
(W.A.) Information

 

(1)           All work
to be assigned under this contract shall relate directly to one or more of the
work areas listed in the Statement of Work.

 

(2)           Each W.A.
shall be written for the conduct of specific, finite task.

 

(3)           Each new
W.A. shall be numbered serially beginning with 01.

 

(4)           Each W.A.
shall be completed on form entitled “NCI Contract Work Assignment” and listed
as an Attachment in Section J of this contract.

 

(5)           Upon
award of the contract, an Administrative Work Assignment as shown in
SECTION J, Attachments, shall be issued on a yearly basis. This Work
Assignment will cover the expenditures necessary for the administration of the
contract.

 

b.             Initiation of a W.A.

 

(1)           The
Project Officer will initiate Part I of the W.A.

 

(2)           The
Contractor shall complete Part II and obtain the appropriate signature. The
Contractor shall forward the proposed W.A. to the Project Officer.

 

(3)           Upon
receipt of the proposed W.A. and after determining that the proposed W.A. is
acceptable, the Project Officer will sign Part II to indicate recommendation
for approval and forward to the Contracting Officer.

 

(4)           Upon
receipt the Contracting Officer will review the proposed W.A.

 

(a)           If
approved, the Contracting Officer will sign Part II to indicate approval and
will forward the W.A. to the Contractor with a copy to the Project Officer.

 

(b)           If not approved, the Contracting Officer
will notify the Project Officer, stating the reasons for disapproval.

 

10

 

(5)           After
receipt of the approved W.A., the Contractor shall begin work. The period of
performance shall never precede the Contracting Officer approval date.

 

c.             Modification to a
W.A.

 

(1)           Each amendment to an existing Work
Assignment shall contain the original W.A. number and shall designate a
modification number. Modification numbers for each W.A. shall be serially
numbered beginning with 01 (for example, Work Assignment 01, Modification No.
01).

 

(2)           Each W.A. Modification shall set forth in
specific detail which portion(s) of the W.A. is to be modified. All Cost/Labor
modifications shall be in the following format:

 

	
   

  	
   

  	
  Authorized
  to Date

  	
   

  	
  This
  Modification

  	
   

  	
  Revised
  Estimate

  	
   

  
	
  Cost Elements

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  (List Each Element)

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

d.             Conclusion of a W.A.

 

(1)           For each
W.A. performed, the Contractor shall prepare PART III of the Work Assignment
for submission to the Contracting Officer.

 

(2)           This PART
III submission shall include all actual information (cost, and deliverables)
relative to the W.A.

 

(3)           PART III
of the W.A. shall be submitted as soon as possible and not to exceed three
months after the closing date of the W.A. For those work assignments which
expire within three months prior to the contract expiration date. PART III of
the Work Assignment shall be submitted on the final contract day.

 

(4)           After
verification that all work is complete and deliverables have been received and
accepted, the Project Officer will sign part III of the W.A. to indicate
recommendation for approval and forward the W.A. to the Contracting Officer.

 

(5)           After
verification that the W.A. has been satisfactorily completed, the Contracting
Officer will approve completion of the W.A. by signing Part III of the W.A. and
forward to the Contractor.

 

ARTICLE G.4. INVOICE SUBMISSION/CONTRACT
FINANCING REQUEST

 

a.             Invoice/Financing Request Instructions for
NIH Cost-Reimbursement Type Contracts NIH(RC)-I are attached and made part of
this contract. The instructions and the following directions for the submission
of invoices/financing request must be followed to meet the requirements of a
“proper” payment request pursuant to FAR 32.9.

 

(1)           Invoices/financing requests shall be
submitted as follows:

 

An original and two copies to the following designed billing office:

 

Contracting Officer

Research Contracts Branch

National Cancer Institute, NIH

EPS, Room 620

6120 EXECUTIVE BLVD MSC 7224

BETHESDA MD 20892-7224

 

(2)           Inquiries regarding payment of invoices
should be directed to the designed billing office, (301)496-8611.

 

(3)           Inquiries regarding actual payment of invoices
should be direct to the designed payment office, (301)496-6452.

 

11

 

b.             Each invoice shall include a summary of
costs incurred on each work assignment. The total costs incurred on all work
assignments for the month shall match the total amount billed on the invoice.

 

c.             Fee billed under this contract shall be
based upon total costs excluding equipment costs.

 

ARTICLE G.5.
CONTRACT FINANCIAL REPORT

 

a.             Financial reports on the attached form NIH
2706, Financial Report of Individual Project/Contract, shall be submitted by
the Contractor in accordance with the Instructions for Completing Form NIH
2706, which accompany the form, in an original and two copies, not later than
the 30th working day after the close of the reporting period. The line entries
for subdivisions of work and elements of costs (expenditure categories) which
shall be reported within the total contract are discussed in paragraphe.,
below. Subsequent changes and/or additions in the line entries shall be made in
writing.

 

b.             Unless otherwise started in that part of
the Instructions for Completing Form NIH 2706, entitled “PREPARATION INSTRUCTIONS,” all columns A
through J, shall be completed for each report submitted.

 

c.             The first financial reports shall cover
the period consisting of the FIRST FULL THREE CALENDAR MONTHS following the
date of the contract in addition to any fractional part of the initial month.
Thereafter, reports will be on a quarterly basis.

 

d.             The Contracting Officer may require the
Contractor to submit detailed support for costs contained in one or more
interim financial reports. This clause does not supersede the record retention
requirements in FAR Part 4.7.

 

e.             The listing of expenditure categories to
be reported is incorporated within the Financial Report of Individual
Project/Contract, NIH 2706, SECTION J, ATTACHMENT 4, attached hereto and
made a part of this contract.

 

f.              The Government may unilaterally revise
the NIH 2706 to reflect the allotment of additional funds.

 

ARTICLE G.6.
INDIRECT COST RATES

 

In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter
1) Clause 52.216-7 (d) (2), Allowable Cost and Payment incorporated by
reference in this contract in Part II, section I, the cognizant
Contracting Officer representative responsible for negotiating provisional
and/or final indirect cost rates is identified as follows:

 

Director, Division of Financial Advisory Services

Officer of Contracts Management

National Institutes of Health

6100 Building, Room 6B05

6100 EXECUTIVE BLVD MSC-7540

BETHESDA MD 20892-7540

 

These rates are hereby incorporated without further action of the
Contracting Officer.

 

ARTICLES
G.7. GOVERNMENT PROPERTY

 

a.             In additional to the requirements of the
clause, GOVERNMENT PROPERTY, incorporated in SECTION I of this contract,
the Contractor shall comply with the provisions of DHHS Publication, Contractor’s Guide for Control of Government Property,
1990, which is incorporated into this contract by reference. Among
other issues, this publication provides a summary of the Contractor’s
responsibilities regarding purchasing authorizations and inventory and
reporting requirements under the contract. A copy of this publication is
available upon request to the Contracts Property Administrator.

 

This contract’s Contracts Property Administrator is:

 

12

 

Contracts Property Administrator

Division of Personal Property Services, NIH

6011 Building, Suite 637

6011 EXECUTIVE BLVE MSC 7670

BETHESDA MD 20852-7670

(301) 496-6466

 

b.             Notwithstanding the provisions outlined in
the DHHS Publication.  Contractor’s Guide for Control of Government Property,
1990 which is incorporated in this contract in paragraph a. above, the
contractor shall use the form entitled, “Report of Government Owned, Contractor
Held Property” for performing annual inventories required under this contract.
This form is included as an attachment in SECTION J of this contract.

 

c.             Contractor-Acquired
Under Government Property - Schedule I-B

 

Pursuant to the clause, GOVERNMENT PROPERTY, incorporated in this
contract, the Contractor will be authorized to acquire the property listed in
the attached Schedule I-B for use in direct performance of the contract,
following receipt of the Contracting Officers written approval, based on
contractor-furnished prices and evidence of competition.

 

d.             Property Acquired
under Predecessor Contract - Schedule II-A

 

Pursuant to the clause, GOVERNMENT PROPERTY, incorporated in this
contract, the Contract is hereby authorized to retain custody of all Government
Property acquired or furnished under predecessor Contract No. N02-CP-71001 for
use in direct performance of this contract. Accountability for the items is
hereby authorized to be transferred to this contract from the predecessor
contract. Upon completion of each contract, the contractor agrees to furnish to
the Contracting Officer, without delay, the inventory schedule covering
all Government Property furnished or acquired for use in the performance of the
predecessor contract as provided by the clause, GOVERNMENT PROPERTY, of that
contract and the instructions contained in DHHS Publication entitled, Contractor’s
Guide for control of Government Property, (1990).

 

ARTICLE G.8.
POST AWARD EVALUATION OF CONTRACTOR PERFORMANCE

 

a.             Contractor
Performance Evaluations

 

Interim and final evaluations of contractor performance will be
prepared on this contract in accordance with FAR 42.15. The final performance
evaluation will be prepared at the time of completion of work. In addition to
the final evaluation, interim evaluations will be prepared annually to coincide
with the anniversary date of the contract.

 

Interim and final evaluations will be provided to the Contractor as
soon as practicable after completion of the evaluation. The Contractor will be
permitted thirty days to review the document and to submit additional
information or a rebutting statement. Any disagreement between the parties
regarding an evaluation will be referred to an individual one level above the
Contracting Officer, whose decision will be final.

 

Copies of the evaluations, contractor responses, and review comments,
if any, will be retained as part of the contract file, and may be used to
support future award decisions.

 

b.             Electronic
Access to Contractor Performance Evaluations

 

Contractors that have Internet capability may access evaluations
through a secure Web site for review and comment by completing the registration
form that can be obtained at the following address:

http://ocm.od.nih.gov/cdmp/cps contractor.htm

 

The registration process requires the contractor to identify an
individual that will serve as a primary contact and who will

 

13

 

be authorized access to the evaluation for review and comment. In
addition, the contractor will be required to identify an alternate contact who
will be responsible for notifying the cognizant contracting official in the
event the primary contact is unavailable to process the evaluation within the
required 30-day time frame.

 

SECTION
H - SPECIAL CONTRACT REQUIREMENTS

 

ARTICLES
H.1. REIMBURSEMENT OF COSTS FOR INDEPENDENT RESEARCH AND DEVELOPMENT PROJECTS

 

The primary purpose of the Public Health Service (PHS) is to support
and advance independent research within the scientific community. This support
is provided in the form of contracts and grants totaling approximately 7
billion dollars annually. PHS has established effective, time tested and well
recognized procedures for stimulating and supporting this independent research
by selecting from multitudes of applications those research projects most
worthy of support within the constraints of its appropriations. The
reimbursement through the indirect cost mechanism of independent research and
development costs not incidental to product improvement would circumvent this
competitive process.

 

To ensure that all research and development projects receive similar
and equal consideration, all organizations may compete for direct funding of
independent research and development projects they consider worthy of support
by submitting those projects to the appropriate Public Health Service grant
office for review. Since these projects may be submitted for direct funding,
the Contractor agrees that no costs for any independent research and
development project, including all applicable indirect costs, will be claimed
under this contract.

 

ARTICLE H.2.
HUMAN SUBJECTS

 

It is hereby understood and agreed that research involving human
subjects shall not be conducted under this contract, and that no material
developed, modified, or delivered by or to the Government under this contract,
or any subsequent modification of such material, will be used by the Contractor
or made available by the Contactor for use by anyone other that the Government,
for experimental or therapeutic use involving humans without the prior written
approval of the Contracting Officer.

 

ARTICLE
H.3. HUMAN MATERIALS

 

It is understood that the acquisition and supply of all human specimen
material (including fetal material) used under this contract will be obtained
by the Contractor in full compliance with applicable State and Local laws and
the provisions of the Uniform Anatomical Gift Act in the United States and that
no undue inducements, monetary or otherwise, will be offered to any person to
influence their donation of human material.

 

ARTICLE H.4.
NEEDLE EXCHANGE

 

	
  a.

  	
   

  	
  Pursuant to Public Law(s) citied in paragraph b., below contract
  funds shall not be used to carry out any program of distributing sterile
  needles or syringes for the hypodermic injection of any illegal drug.

  
	
   

  	
   

  	
   

  
	
  b.

  	
   

  	
  Public Law and Section No.

  	
   

  	
  Fiscal Year

  	
   

  	
  Period Covered

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  P.L. 106-554, Section 505

  	
   

  	
  2001

  	
   

  	
  (10/1/00 - 9/30/01)

  

 

ARTICLE H.5.
PRIVACY ACT

 

This procurement action requires the Contractor to do one more of the
following; design, develop, or operate a system of

 

14

 

records on individuals to accomplish an agency function in accordance
with the Privacy Act of 1974, Public Law 93-579, December 31, 1974 (5 USC
552a) and applicable agency regulations. Violation of the Act may involve the
imposition of criminal penaltics.

 

The Privacy Act System of Records applicable to this projects is Number
09-25-0200. This document is incorporated into this contract as Attachment 6.

 

ARTICLE H.6. CONFIDENTIALITY OF
INFORMATION

 

The following information is covered by HHSAR Clause 352.224-70,
Confidentiality of Information (APRIL 1984):

 

•              Identification of
Specimen source or donor name;

•              All records of
manipulations on all sepecimens;

•              Information
concerning the identification of the patient, the diagnosis, demographic
information or other such information;

•              Written, hard-copy
records of inventory sheets.

 

ARTICLE H.7.
PUBLICATION AND PUBLICITY

 

The contractor shall acknowledge the support of the National Institutes
of Health whenever publicizing the work under this contract in any media by
including an acknowledgement substantially as follows:

 

“This project has been funded in whole or in part with Federal funds
from the National Cancer Institute, National Institutes of Health, under
Contractor No. N02-CP-11001.”

 

ARTICLES
H.8. PRESS RELEASES

 

	
  a.

  	
   

  	
  Pursuant to Public Law(s) cited in paragraph b., below, the
  contractor shall clearly state, when issuing statements, press releases,
  requests for proposals, bid solicitations and other documents describing
  projects or programs funded in whole or in part with Federal money: (1) the
  percentage of the total costs of the program or project which will be
  financed with Federal money; (2) the dollar amount of Federal funds for the
  projects or program; and (3) the percentage and dollar amount of the total
  costs of the project or program that will be financed by nongovernmental
  sources.

  
	
   

  	
   

  	
   

  
	
  b.

  	
   

  	
  Public Law and Section No.

  	
   

  	
  Fiscal year

  	
   

  	
  Period covered

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  P.L. 106-554, Section 505

  	
   

  	
  2001

  	
   

  	
  (10/1/00-9/30/01)

  

 

ARTICLE H.9. REPORTING MATTERS INVOLVING
FRAUD, WASTE AND ABUSE

 

Anyone who becomes aware of the existence or apparent existence of
fraud, waste and abuse in NIH funded programs is encouraged to report such
matters to the HHS Inspector General’s Office in writing or on the Inspector
General’s Hotline. The toll free number is 1-800-HHS-TIPS
(1-800-447-8477).  All
telephone calls will be handled confidentially. The e-mail address is Htips@os.dhhs.gov and the mailing address
is;

 

Office of Inspector General

Department of Health and Human Services

TIPS HOTLINE

P.O. Box 23489

Washington, D.C. 20026

 

Information regarding procedural matters is contained in the NIH Manual
Chapter 1754, which is available on
(http://www3.od.nih.gov/oma/mantial/chapters/management/1754/)

 

15

 

PART II - CONTRACT CLAUSES

 

SECTION I
- CONTRACT CLAUSES

 

ARTICLE
1.1. GENERAL CLAUSES FOR A COST-REIMBURSEMENT SERVICE CONTRACT - FAR 52.252-2,
CLAUSES INCORPORATED BY REFERENCE (FEBRUARY 1998)

 

This contract incorporates the following clauses by reference, with the
same force and effect as if they were given in full text. Upon request, the
Contracting Officer will make their full text available. Also, the full text of
a clause may be accessed electronically at this address:
http://www.arnet.gov/far/.

 

a.             FEDERAL
ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES:

 

	
  FAR

  CLAUSE NO.

  	
   

  	
  DATE

  	
   

  	
  TITLE

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.202-1

  	
   

  	
  Oct 1995

  	
   

  	
  Definitions

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.203-3

  	
   

  	
  Apr 1984

  	
   

  	
  Gratuities (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.203-5

  	
   

  	
  Apr 1984

  	
   

  	
  Covenant Against Contingent Fees (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.203-6

  	
   

  	
  Jul 1995

  	
   

  	
  Restrictions on Subcontractor Sales to the Government (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.203-7

  	
   

  	
  Jul 1995

  	
   

  	
  Anti-Kickback Procedures(Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.203-8

  	
   

  	
  Jan 1997

  	
   

  	
  Cancellation, Rescission, and Recovery of Funds for Illegal or
  Improper Activity (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.203-10

  	
   

  	
  Jan 1997

  	
   

  	
  Price or Fee Adjustment for Illegal or Improper Activity (Over
  $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.203-12

  	
   

  	
  Jun 1997

  	
   

  	
  Limitation on Payments to Influence Certain Federal Transactions
  (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.204-4

  	
   

  	
  Aug 2000

  	
   

  	
  Printed or Copied Double-Sided on Recycled Paper (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.209-6

  	
   

  	
  Jul 1995

  	
   

  	
  Protecting the Government’s Interests When Subcontracting With
  Contractors Debarred, Suspended, or Proposed for Debarment (Over $25,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.215-2

  	
   

  	
  Jun 1999

  	
   

  	
  Audit and Records - Negotiation (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.215-8

  	
   

  	
  Oct 1997

  	
   

  	
  Order of Precedence - Uniform Contract Format

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.215-10

  	
   

  	
  Oct 1997

  	
   

  	
  Price Reduction for Defective Cost or Pricing Data

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.215-12

  	
   

  	
  Oct 1997

  	
   

  	
  Subcontractor Cost or Pricing Data (Over $500,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.215-14

  	
   

  	
  Oct 1997

  	
   

  	
  Integrity of Unit Prices (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.215-15

  	
   

  	
  Dec 1998

  	
   

  	
  Pension Adjustments and Asset Reversions

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.215-18

  	
   

  	
  Oct 1997

  	
   

  	
  Reversion or Adjustment of Plans for Post-Retirement Benefits (PRB)
  other than Pensions

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.215-19

  	
   

  	
  Oct 1997

  	
   

  	
  Notification of Ownership Changes

  

 

16

 

	
  52.215-21

  	
   

  	
  Oct 1997

  	
   

  	
  Requirements for Cost or Pricing Data or Information Other Than Cost
  or Pricing Data - Modifications

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.216-7

  	
   

  	
  Mar 2000

  	
   

  	
  Allowable Cost and Payment

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.216-8

  	
   

  	
  Mar 1997

  	
   

  	
  Fixed Fee

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.219-8

  	
   

  	
  Oct 2000

  	
   

  	
  Utilization of Small Business Concerns (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.219-9

  	
   

  	
  Oct 2000

  	
   

  	
  Small Business Subcontracting Plan (Over $500,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.219-16

  	
   

  	
  Jan 1999

  	
   

  	
  Liquidated Damages - Subcontracting Plan (Over $500,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.222-2

  	
   

  	
  Jul 1990

  	
   

  	
  Payment for Overtime Premium (Over $100,000) (Note: The dollar amount
  in paragraph (a) of this clause is $0 unless otherwise specified in the
  contract.)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.222-3

  	
   

  	
  Aug 1996

  	
   

  	
  Convict Labor

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.222-26

  	
   

  	
  Feb 1999

  	
   

  	
  Equal Opportunity

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.222-35

  	
   

  	
  Apr 1998

  	
   

  	
  Affirmative Action for Disabled Veterans and Veterans of the Vietnam
  Era

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.222-36

  	
   

  	
  Jun 1998

  	
   

  	
  Affirmative Action for Workers with Disabilities

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.222-37

  	
   

  	
  Jan 1999

  	
   

  	
  Employment Reports on Disabled Veterans and Veterans of the Vietnam
  Era

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.223-6

  	
   

  	
  Jan 1997

  	
   

  	
  Drug-Free Workplace

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.223-14

  	
   

  	
  Oct 2000

  	
   

  	
  Toxic Chemical Release Reporting

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.225-1

  	
   

  	
  Feb 2000

  	
   

  	
  Buy American Act - Balance of Payments Program - Supplies

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.225-13

  	
   

  	
  Jul 2000

  	
   

  	
  Restrictions on Certain Foreign Purchases

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.227-1

  	
   

  	
  Jul 1995

  	
   

  	
  Authorization and Consent

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.227-2

  	
   

  	
  Aug 1996

  	
   

  	
  Notice and Assistance Regarding Patent and Copyright Infringement
  (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.227-3

  	
   

  	
  Apr 1984

  	
   

  	
  Patent Indemnity

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.227-14

  	
   

  	
  Jun 1987

  	
   

  	
  Rights in Data - General

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.232-9

  	
   

  	
  Apr 1984

  	
   

  	
  Limitation on Withholding of Payments

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.232-17

  	
   

  	
  Jun 1996

  	
   

  	
  Interest (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.232-20

  	
   

  	
  Apr 1984

  	
   

  	
  Limitation of Cost

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.232-23

  	
   

  	
  Jan 1986

  	
   

  	
  Assignment of Claims

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.232-25

  	
   

  	
  Jun 1997

  	
   

  	
  Prompt Payment

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.232-34

  	
   

  	
  May 1999

  	
   

  	
  Payment by Electronic Funds Transfer—Other Than Central Contractor
  Registration

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.233-1

  	
   

  	
  Dec 1998

  	
   

  	
  Disputes

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.233-3

  	
   

  	
  Aug 1996

  	
   

  	
  Protest After Award, Alternate I (Jun 1985)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.242-1

  	
   

  	
  Apr 1984

  	
   

  	
  Notice of Intent to Disallow Costs

  

 

17

 

	
  52.242-3

  	
   

  	
  Oct 1995

  	
   

  	
  Penalties for Unallowable Costs (Over $500,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.242-4

  	
   

  	
  Jan 1997

  	
   

  	
  Certification of Final Indirect Costs

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.242-13

  	
   

  	
  Jul 1995

  	
   

  	
  Bankruptcy (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.243-2

  	
   

  	
  Aug 1987

  	
   

  	
  Changes - Cost Reimbursement, Alternate I (Apr 1984)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.244-2

  	
   

  	
  Aug 1998

  	
   

  	
  Subcontracts, Alternate II (Aug 1998) *If written consent to
  subcontract is required, the identified subcontracts are listed in
  ARTICLE B, Advance Understandings.

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.244-5

  	
   

  	
  Dec 1996

  	
   

  	
  Competition in Subcontracting (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.245-5

  	
   

  	
  Jan 1986

  	
   

  	
  Government Property (Cost-Reimbursement, Time and Material, or
  Labor-Hour Contract)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.246-25

  	
   

  	
  Feb 1997

  	
   

  	
  Limitation of Liability - Services (Over $100,000)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.249-6

  	
   

  	
  Sep 1996

  	
   

  	
  Termination (Cost-Reimbursement)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.249-14

  	
   

  	
  Apr 1984

  	
   

  	
  Excusable Delays

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  52.253-1

  	
   

  	
  Jan 1991

  	
   

  	
  Computer Generated Forms

  

 

b.             DEPARTMENT OF HEALTH AND HUMAN SERVICES
ACQUISITION REGULATION (HHSAR) (48 CFR CHAPTER 3) CLAUSES:

 

	
  HHSAR

  CLAUSE NO.

  	
   

  	
  DATE

  	
   

  	
  TITLE

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  352.202-1

  	
   

  	
  Jan 2001

  	
   

  	
  Definitions - with Alternate paragraph (h) (Jan 2001)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  352.228-7

  	
   

  	
  Dec 1991

  	
   

  	
  Insurance - Liability to Third Persons

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  352.232-9

  	
   

  	
  Apr 1984

  	
   

  	
  Withholding of Contract Payments

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  352.233-70

  	
   

  	
  Apr 1984

  	
   

  	
  Litigation and Claims

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  352.242-71

  	
   

  	
  Apr 1984

  	
   

  	
  Final Decisions on Audit Findings

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  352.270-5

  	
   

  	
  Apr 1984

  	
   

  	
  Key Personnel

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  352.270-6

  	
   

  	
  Jul 1991

  	
   

  	
  Publications and Publicity

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  352.270-7

  	
   

  	
  Jan 2001

  	
   

  	
  Paperwork Reduction Act

  

 

 

[End of GENERAL CLAUSES FOR A COST-REIMBURSEMENT SERVICE CONTRACT -
Rev. 2/2001].

 

ARTICLE 1.2 AUTHORIZED SUBSTITUTION OF
CLAUSES

 

ARTICLE 1.1. of this SECTION is hereby modified as follows:

 

FAR Clause 52.219-9, SMALL BUSINESS SUBCONTRACTING PLAN
(OCTOBER 2000), and FAR Clause 52.219-16, LIQUIDATED
DAMAGES—SUBCONTRACTING PLAN (JANUARY 1999) are deleted in their entirety.

 

FAR Clause 52.232-20, LIMITATION OF COST, is deleted in its entirety and
FAR Clause 52.232-22, LIMITATION OF

 

18

 

FUNDS (APRIL 1984) is substituted therefor.  Note: When
this contract is fully funded, FAR Clause 52.232-22, LIMITATION OF FUNDS will
no longer apply and FAR Clause 52.232-20, LIMITATION OF COST will become
applicable.

 

ARTICLE 1.3. ADDITIONAL CONTRACT CLAUSES

 

This contract incorporates the following clauses by reference, with the
same force and effect, as if they were given in full text. Upon request, the
contracting officer will make their full text available.

 

a.             FEDERAL
ACQUISITION REGULATION (FAR) (48 CFR CHAPTER ?) CLAUSES

 

	
  (1)

  	
  FAR 52.215-17, Waiver of Facilities Capital Cost of Money
  (OCTOBER 1997).

  
	
   

  	
   

  
	
  (2)

  	
  FAR 52.219-6, Notice of Total Small Business Set-Aside
  (JULY 1996).

  
	
   

  	
   

  
	
  (3)

  	
  FAR 52.219-14, Limitations on Subcontracting (DECEMBER 1996).

  
	
   

  	
   

  
	
  (4)

  	
  FAR 52.224-1, Privacy Act Notification (APRIL 1984).

  
	
   

  	
   

  
	
  (5)

  	
  FAR 52.224-2, Privacy Act (APRIL 1984).

  
	
   

  	
   

  
	
  (6)

  	
  FAR 52.227-14, Rights in Data - General (JUNE 1987).

  
	
   

  	
   

  
	
  (7)

  	
  FAR 52.247-63, Preference for U.S. Flag Air Carriers
  (JANUARY 1997).

  
	
   

  	
   

  
	
  (8)

  	
  FAR 52.251-1, Government Supply Sources (APRIL 1984).

  

 

b.             DEPARTMENT OF HEALTH AND HUMAN SERVICES
ACQUISITION REGULATION/PUBLIC HEALTH SERVICE ACQUISITION REGULATION (HHSAR)/(PHSAR)
(48 CHAPTER 3) CLAUSES:

 

	
  (1)

  	
  HHSAR 352.223-70, Safety and Health (JANUARY 2001).

  
	
   

  	
   

  
	
  (2)

  	
  HHSAR 352.224-70, Confidentiality of Information (APRIL 1984).

  

 

c.             NATIONAL
INSTITUTES OF HEALTH (NIH) RESEARCH CONTRACTING (RC) CLAUSES:

 

The following clauses are attached and made a part of this contract:

 

	
  (1)

  	
  NIH (RC)-7, Procurement of Certain Equipment (APRIL 1984) (OMB
  Bulletin 81-16).

  

 

ARTICLE 1.4. ADDITIONAL FAR CONTRACT
CLAUSES INCLUDED IN FULL TEXT

 

This contract incorporates the following clauses in full text.

 

FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES:

 

a.             FAR Clause 52.244-6, SUBCONTRACTS FOR COMMERCIAL ITEMS AND COMMERCIAL
COMPONENTS (OCTOBER 1998)

 

(a)           Definition.

 

Commercial item, as
used in this clause, has the meaning contained in the clause at 52.202-1,
Definitions.

 

19

 

Subcontract, as used
in this clause, includes a transfer of commercial items between divisions,
subsidiaries, or affiliates of the Contractor or subcontractor at any tier.

 

(b)           To the maximum extent practicable, the
Contractor shall incorporate, and require its subcontractors at all tiers to
incorporate, commercial items or nondevelopmental items as components of items
to be supplied under this contract.

 

(c)           Notwithstanding any other clause of this
contract, the Contractor is not required to include any FAR provision or
clause, other than those listed below to the extent they are applicable and as
may be required to establish the reasonableness of prices under Part 15, in a
subcontract at any tier for commercial items or commercial components:

 

(1)           52.222-26, Equal Opportunity (E.O. 11246);

(2)           52.222-35, Affirmative Action for Disabled
Veterans and Veterans of the Vietnam Era (38 U.S.C. 4212(a));

(3)           52.222-36, Affirmative Action for Workers
with Disabilities (29 U.S.C. 793); and

(4)           52.247-64, Preference for Privately Owned
U.S.-Flagged Commercial Vessels (46 U.S.C. 1241) (flow down not required for
subcontracts awarded beginning May 1, 1996).

 

(d)           The Contractor shall include the terms of
this clause, including this paragraph (d), in subcontracts awarded under this
contract.

 

20

 

PART
III

 

SECTION J
- LIST OF ATTACHMENTS

 

The following documents are attached and incorporated in this contract:

 

1.             Statement of Work, August 2000, 5 pages.

 

2.             Sample Contract Work Assignment, 4/95, 3 pages.

 

3.             Invoice/Financing Request Instructions for NIH
Cost-Reimbursement Type Contracts, NIH(RC)-1 (5/97), 4 pages.

 

4.             Financial Report of Individual Project/Contract, NIH
2706, (5/97), 1 page.

 

5.             Instructions for Completing form NIH 2706, Financial
Report of Individual Project/Contract, (5/97), 3 pages.

 

6.             Privacy
Act System of Records, Number 09-25-0200, as cited in the Federal Register
Notice issued in Volume 62, Number 66, pages 16596-16602, dated 4/7/97.

 

7.             Safety and Health, HHSAR Clause 352.223-70, (1/01), 1 page.

 

8.             Procurement of Certain Equipment, NIH(RC)-7, 4/1/84, 1
page.

 

9.             Government
Property - Schedule I-B.

 

10.           Government
Property - Schedule II-A.

 

11.           Report of Government Owned, Contractor Held
Property, 1 page.

 

21

 

PART IV

 

SECTION K
- REPRESENTATIONS AND CERTIFICATIONS

 

The following documents are incorporated by reference in this contract:

 

1.             Representations and Certifications, dated
November 14, 2000.

 

 

END of the SCHEDULE

(CONTRACT)

 

22

 

STATEMENT OF WORK

 

ARTICLE C.1.   STATEMENT OF WORK

 

a.             Independently and not as an agent of the
Government, the Contractor shall be required to furnish all the necessary
services, qualified personnel, material, equipment, and facilities, not
otherwise provided by the Government, as needed to perform the Statement of Work
below:

 

1)             The Contractor shall provide the services
described below in accordance with Contractor-developed, Government-approved
protocols:

 

a)             Separation and viable cryopreservation of
blood mononuclear lymphocytes;

 

b)            Separation, aliquoting and storage of
serum, plasma and/or urine as needed;

 

c)             Cryopreservation of bone marrow samples;

 

d)            Storage of tumor extracts;

 

NOTE:   Tumor extracts are not
synonymous with the preparation of tumor antigens. Specific protocols will be
provided by the NCI for extract preparations.

 

e)             Cryopreservation of whole tumor tissue;

 

NOTE: Specimens may range in size from 0.5 - 100 or more grams. Tumor
tissues will be cut to specified sizes and flash frozen in liquid nitrogen.
They will then be stored in vials in liquid nitrogen. Tumor lines, which have
already been established, may be viably cryopreserved and stored.

 

f)             Cryopreservation of intact red blood
cells;

 

g)            Viable cryopreservation of previously
established lymphoblastoid cell lines;

 

h)            Storage of DNA and other biological
materials as specified by the Project Officer (e.g., pathology slides and
tissue block);

 

i)              Extraction of DNA from biologic
materials;

 

j)              Specimen processing as required by NCI to
preserve special biologic materials;

 

k)             Logging in, labeling and tracking of each
vial of each sample employing an NCI developed computerized specimen tracking
system, including all laboratory safeguards to insure the fidelity and purity
of each sample.

 

NOTE: In one “typical” day, the most labor-intensive procedure would be
the processing of whole blood for cryopreservation of leukocytes.  As many as 30 samples of approximately 30 ml
each could be received.

 

l)              Maintenance of the previously-established
repository currently containing more than 2.0 million biological specimens and
allowance for an estimated increase of up to 100% of freezer storage space.

 

	
  Statement of Work

  	
   

  	
  ATTACHMENT 1

  
	
  (August 2000)

  	
   

  	
   

  

 

1

 

m)  Under the direction of the Project Officer conduct
laboratory methods studies that establish optimal conditions for collection,
processing, shipping and storage of biologic materials.

 

Processing services shall be available routinely between the hours of
9:00 a.m. and 2:00 p.m., Monday through Friday and at any other time (including
nights, weekends and holidays) by special arrangement, usually with advance
notice. A laboratory staff member shall be available during nonbusiness hours
for emergency specimen processing (as might occur when a patient dies). A
biohazard area adequate for processing specimens with Acquired Immunodeficiency
Syndrome (AIDS) shall be available for the processing of all biologic samples.

 

2)             The Contractor shall supply messenger
service to pick up specimens or inter-laboratory communication from medical
care facilities in the Washington, D.C., area or at area transportation centers
(i.e., Dulles International, D.C. National and Baltimore/Washington
International Airports). This messenger service shall be supplied by the
Contractor and not subcontracted to commercial carriers. All specimens
submitted to the laboratory for processing shall be scheduled in advance,
except in emergencies as detailed below. 
Specimens shall be delivered to the Contractor’s laboratory within four
hours of notification for pick-up. 
Specimens shall be protected from temperature extremes by use of
insulated containers or other acceptable means as needed. A portable liquid
nitrogen container for transport of frozen cells or tumor specimens shall also
be required. Only specimens provided by or approved by the Project Officer
shall be accepted for processing and storage by the Contractor.

 

3)             The Contractor shall be responsible for
recording and monitoring the location of all specimens that are being sent or
received through use of a logbook of all requests and specimens. The Contractor
shall be responsible for monitoring, shipping and receipt of specimens to
minimize delay or loss. If a specimen is not received within four hours of
expected delivery, the Contractor shall inform the Project officer by
telephone. An after-hours telephone number of the Contractor’s staff member
shall be available to assist in this follow-up and the staff member shall be
available at that number. The Contractor shall be responsible for immediately
tracing the location of delinquent specimens not received when expected. All
specimens that are of questionable research value shall be noted and the
Project Officer notified by telephone within 24 hours, as well as in writing
within 3 business days, providing identifying names or numbers, quantity, place
of origin, a concise narrative description of the event, etc., so that
appropriate action can be initiated. The Contractor shall designate a specific
individual to be responsible for after-hours specimen processing and name an
alternate to act when the primary person is not available.

 

4)             The Contractor shall maintain a repository
of biologic specimens for the NCI Division of Cancer Epidemiology and Genetics
(DCEG). This repository shall include frozen serum, plasma, urine, tumor
tissue, tumor tissue extracts, whole red blood cells, separated and frozen
white blood cells, or fractions of white blood cell populations, bone marrow
cells, body fluids, lymphoblastoid cell lines, DNA, stool specimens or smears
or slides, pathology paraffin blocks, and other types of specimens as specified
by the Project Officer. These materials shall be maintained at optimum
temperatures for long-term storage, including liquid nitrogen, if appropriate.

 

5)             All specimens will be submitted to the
Contractor, accompanied by written identification of the specimen source, using
forms supplied by the Project Officer, Specimens from members of NCI-associated
families will be submitted with a unique identification number to insure compatibility
with NCI laboratory computer databases. Specimens shall be assigned a unique
code number, which shall be the only identification of the specimen in future
laboratory processing, dispersal, etc. This code numbers shall comply with the
format and convention established by the NCI Project Officer. The name of the
donor shall not be used in labeling of specimens or in correspondence
concerning the specimen by laboratory personnel. Such labeling shall uniquely
identify each vial of each specimen and the quality of that individual vial
will  be recorded and updated as needed
in the NCI-developed computer system.

 

6)             The Contractor shall provide and train
primary and backup staff in the operation of a computerized record

 

2

 

system for specimens which has been developed and furnished by the
Project Officer. Using this system, the laboratory shall keep records of all
manipulation on all specimens and accurately enter data on each specimen. The
data shall include but not be limited to vial identification number, study ID,
material type and material description, volume, weight or cell concentration,
freezer location, subject ID, crisis events, data received, specimen vial
quality, etc. Data shall be entered into the system, with attention to extreme
accuracy, within 48 hours of receipt, or as specified by the NCI Project
Officer. The Contractor shall be responsible for extracting this information
from either data forms or floppy disks, which will be transmitted with the
samples. The Contractor shall also use this system to monitor and track all
activities related to specimens. The Project Officer will supply computer
support for generating management reports for the contractor on a regular
basis.

 

7)             The Contractor shall prepare a variety of
specimens for storage. Specifically, white blood cell separation, fractionation
and viable cryopreservation, red blood cell cryopreservation, serum separation
and storage of aliquots of 0.5 ml, plasma separation and storage, tumor tissue
freezing, tumor tissue extracts, urine, serum, or blood fluid lyophilization,
freezing and/or extraction of stool specimens and other techniques as required.
Specimens shall be stored in containers impervious to entry of CO2
so that they can be shipped on dry ice. 
Shipment of specimen in liquid nitrogen “dry shippers” may also be
required. In order to ensure the viability of valuable specimens, the
contractor shall be prepared to have appropriate personnel travel to a contract
site, foreign or domestic, to train local staff on optimal techniques for
freezing viable material.

 

8)             Freezers shall be equipped with a stylus
recording system indicating consistency of temperature, which shall be reviewed
on a scheduled basis each day at specified time. Freezer malfunctions must give
warning by means of an alarm system. The Contractor must provide a central
alarm system monitored 24-hours a day, 365 days a year. A switch-operated
electric generator of appropriate wattage for these particular freezers shall
be hooked up and be maintained on standby in the event of a major power outage.
Liquid nitrogen freezers must have automatic filling mechanisms drawing on a
constant central source of liquid nitrogen with emergency back up. All
unplanned defrostings must be logged, giving date and times during which
defrostings were in effect and temperature reached, and reported to the Project
Officer by telephone and in writing as described above.

 

9)             The laboratory shall keep clear records of
all manipulations on all specimens and carefully document specimen type,
volume, cell concentration, source, “crisis events”, etc. for each sample. The
exact freezer location shall be known for each specimen and shall be kept in a
master log that is easy to understand. Information shall be supplied routinely
to the NCI Project Officer on forms designed and supplied by NCI in conjunction
with laboratory personnel. These records shall include number of vials, exact
location of vials and specimen type. The Contractor shall conduct an inventory
totaling 20 percent of all stored specimens on an annual basis and include the
results in the Annual Report. The annual inventory shall be conducted in a
manner that results in a complete inventory of all stored specimens over the
course of the contract. Thorough quality control protocols must be designed,
documented and approved by the NCI Project Officer. These protocols must be
rigorously implemented in the conduct of the inventories. The results of each
inventory shall be documented in the annual Technical Progress Report.

 

10)           The Contractor shall respond only to written
(electronic mail will acceptable) requests for biological specimens from
collaborating investigators, which have been approved by the NCI Project
Officer or his/her designee(s). Specimens shall not be sent to any investigator
without a written request from the NCI Project Officer or his/her designee(s).
A copy of this written request and Contractor-generated correspondence shall be
sent to the NCI Project Officer. All written requests for specimen distribution
shall be acted upon within four working days of receipt, unless permission to
delay such action is obtained from the Project Officer.

 

The Contractor shall not supply the outside collaborator with any
information concerning the biological specimens other than code number,
specimen type or other information essential to specimen processing.

 

3

 

Requests for identification of the patient, the diagnosis, demographic
data or other such information shall be referred to the NCI Project Officer.

 

The Contraction shall NEVER send out the last vial from a
particular specimen without explicit authorization from the Project Officer.

 

11)           The Contractor shall prepare specimens for
shipment, supply shipping containers appropriate to maintain specimens in the
proper state (cool, frozen, deep frozen, etc.) and make arrangements through
commercial air freight companies and other carriers to send biologic specimens
to collaborating investigators in an expeditious (e.g., overnight or same day)
fashion. For immunologic or genetic typing studies, for example, the Contractor
shall prepare specimens for delivery to the local HLA typing laboratory or
immune function laboratory in a suitable form. The local in-house delivery
service shall be used for these particular specimens to ensure expeditious
delivery under optimum conditions. In some cases, commercial freight companies
shall be used in overnight shipments to investigators in other cities. The Contractor
shall be responsible for notifying the receiving laboratory of the specimens’
shipment and anticipated arrival time to insure that the receiving laboratory
is prepared to receive the specimens. All specimens for both immunologic
testing and HLA typing and serum or other type storage shall be processed by
the Contractor. Peripheral blood cells shall be aliquotted for storage in
suitable quantities for subsequent testing. Other specimens, such as red blood
cells, plasma, serum, urine, stool, tumor tissue, and body fluids shall be
processed for storage in appropriate aliquots.

 

12)           A large repository of sera and cells used
for immunogenetic tissue typing shall be inventoried, stored and maintained
under this contract. This shall include preparing appropriate inventory forms
for specimen storage, retrieval and shipment.

 

The laboratory shall retain written, hard copy records of inventory
sheets and shall supply copies in suitable form for computer entry by NCI
computer support personnel. Laboratory personnel shall verify the accuracy of
information as it is entered in the computer against the original data, and
errors shall be corrected.

 

13)   The Contractor shall be prepared to process
the following quantities of materials:

 

	
  Material

  	
   

  	
  Max Daily

  (vials)

  	
   

  	
  Typical
  Total

  Monthly
  Volume

  (Individual Sample vials)

  	
   

  
	
  WBC Cryopreservation

  	
   

  	
  60

  	
   

  	
  250

  	
   

  
	
  Plasma/serum aliquoting

  	
   

  	
  60

  	
   

  	
  250

  	
   

  
	
  RBC cryopreservation

  	
   

  	
  25

  	
   

  	
  750

  	
   

  
	
  Pelleted lymphocytes

  	
   

  	
  15

  	
   

  	
  600

  	
   

  
	
  Buffy coat preps

  	
   

  	
  20

  	
   

  	
  300

  	
   

  
	
  Receipt frozen vials

  	
   

  	
  10,000

  	
   

  	
  17,000

  	
   

  
	
  Thawing/ aliquotting

  	
   

  	
  N/A

  	
   

  	
  500

  	
   

  
	
  Dispersal of specimens

  	
   

  	
  N/A

  	
   

  	
  10,000

  	
   

  
	
  DNA purification

  	
   

  	
  N/A

  	
   

  	
  400

  	
   

  

 

Although these are ESTIMATES
of the amount of work, the Contractor must be able to accommodate highly
variable amounts of processing and possible changes in specimen types and
volumes depending on the new studies evolving during the contract (e.g.
increased processing of buccal swabs and rinses; gastric juice; feces; urine,
etc.). All prioritization of the specimen processing is determined by the NCI
Project Officer. Not all maximal quantities of each material will arrive on a
given day.

 

4

 

For this aspect of the contract, it is anticipated that technicians
shall be available at least one day per weekend through the entire period of
this contract (the weekend blood samples will be less than 200 ml and from less
than five donors).

 

14)   The Contractor shall handle
international shipments of biological specimens (blood components, urine,
gastric juice, and biopsy specimens) and clearance of these shipments through
U.S. and foreign customs. The Contractor must provide a separate
shipping/customs agent to coordinate shipping, clear specimens through customs
at U.S. entry port, transfer to appropriate courier/express delivery service
for shipment within the U.S., and notify Contractor of all arrangements so that
specimens can be easily tracked. Close coordination is vital because these
samples may need to be kept frozen with dry ice, and freezer-to-freezer
shipping time must be less than 72 hours. Delays of just one or two days will
seriously jeopardize months of scientific and medical work. Large quantities of
samples are shipped from Europe, the East Indies, Africa, China and other
geographic locales. In each instance, the repository Contractor shall have
responsibility for coordinating logistics to insure their timely arrival,
including contracting with appropriate customs brokers and agents to expedite
shipment and customs clearances.

 

15)   The Contractor, with input from
the Project Officer, shall develop methods and procedures that improve the
quality and efficiency of current biologic specimen collection, processing,
shipping or storage protocols.  Examples
of such studies are: Specimen stability with respect to various storage
conditions and analyses; nucleic acid extraction methodology; comparison of
serum and plasma in serologic assays; evaluation of specimen shipping
protocols; evaluation of processing/aliquoting for chip-based approaches;
evaluation of suitable method to preserve RNA, especially mRNA.

 

5

 

CONTRACT WORK ASSIGNMENT (W.A.)

 

	
  Contractor:

  	
  BBI - Biotech Research Laboratories

  	
  W.A. Title:

  
	
   

  	
  Dr. Mark Cosentino

  	
   

  
	
   

  	
  5107 Pegasus Court

  	
   

  
	
   

  	
  Frederick, MD 21704

  	
   

  
	
   

  	
   

  	
   

  
	
  Contract No: N02-CP-11001

  	
   

  

 

	
  W.A.
  No:             Modification
  No.:             

  	
   

  	
  W.A. Originator:

  
	
   

  	
   

  	
   

  
	
  Contracted Task Area:

  	
   

  	
  Date Prepared:

  

 

Part I.              INITIATOR’S
REQUEST

 

A. Period of Performance:
From                             to                             

B. Task Description

 

 

C. Task Leader

 

D. Deliverables

 

E.W.A. Response Due Date:

 

	
  Contract Work Assignment

  	
   

  	
  ATTACHMENT 2

  
	
  April, 1995

  	
   

  	
   

  

 

1

 

CONTRACT WORK ASSIGNMENT (W.A.)

 

	
  Contractor:

  	
  BBI - Biotech Research Laboratories

  	
  Contract No: N02-CP-11001

  
	
   

  	
  Dr. Mark Cosentino

  	
   

  
	
   

  	
  5107 Pegasus Court

  	
   

  
	
   

  	
  Frederick, MD 21704

  	
   

  

 

	
  W.A.
  No:                            Modification
  No:             

  	
   

  	
  Date Prepared:

  

 

Part II.            CONTRACTOR’S
RESPONSE TO W.A. REQUEST

(The Contractor may attach additional sheets to this form to present
requested data.)

 

A.            Estimated Cost and Effort

 

1.             Labor hours - list W.A. leader, specific
individuals to be assigned, labor category, and estimated hours for each.

2.             Labor costs - list by labor category and
total.

3.             Employee benefits.

4.             Direct materials

5.             Travel

6.             Subcontracts

7.             Other direct costs

8.             Indirect costs

9.             Total estimated costs for this Order

10.           Fee

11.           Equipment

12.           Total Estimated Cost and Fee

 

B.            Detailed description of the approach to be
used and of the deliverable(s). (Be specific.)

 

 

APPROVAL TO PROCEED: The Contractor shall not
exceed the estimated W.A. amount, or change the W.A. leader without the prior
written approval of the Project Officer and the Contracting Officer.

 

	
  1.

  	
  For the Contractor:

  	
   

  	
   

  	
  Date:

  	
   

  	
   

  
	
   

  	
  (Signature)

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
  Typed name:

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  2.

  	
  For the Government:

  	
   

  	
   

  	
  Date:

  	
   

  	
   

  
	
   

  	
  (Project
  Officer)

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  Date:

  	
   

  	
   

  
	
   

  	
  (Contracting
  Officer)

  	
   

  	
   

  	
   

  	
   

  
									

 

2

 

CONTRACT WORK ASSIGNMENT (W.A.)

 

	
  Contractor:

  	
  BBI - Biotech Research Laboratories

  	
  Contract No: N02-CP-11001

  
	
   

  	
  Dr. Mark Cosentino

  	
   

  
	
   

  	
  5107 Pegasus Court

  	
   

  
	
   

  	
  Frederick, MD 21704

  	
   

  

 

	
  W.A.
  No:                            Modification
  No.:             

  	
   

  	
  Date Prepared:

  

 

PART III.       CONTRACTOR’S REPORT OF W.A.
PERFORMANCE

 

(The Contractor may attach
additional
sheets to this form to present the requested data.)

 

A.            Actual Cost and Effort

 

1.             Labor hours - list specific
assigned individuals, labor category, and actual hours worked.

2.             Labor costs - list labor category,
individual, and total amount.

3.             Employee benefits

4.             Direct Materials

5.             Travel

6.             Subcontracts

7.             Other direct costs

8.             Indirect costs

9.             Total costs for this W.A.

10.           Fee

11.           Equipment

12.           Total Estimated Cost and Fee

 

B.  Report
of Deliverables

 

 

REVIEW AND APPROVAL OF SATISFACTORY PERFORMANCE

 

The signatures below indicate that the services/products required
under Work Assignment No.        have been
delivered, received and satisfactorily meet the requirements of this Work
Assignment.

 

	
  1.

  	
  For the Contractor:

  	
   

  	
   

  	
  Date:

  	
   

  	
   

  
	
   

  	
  (Signature)

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
  Typed name:

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  2.

  	
  For the Government:

  	
   

  	
   

  	
  Date:

  	
   

  	
   

  
	
   

  	
  (Project
  Officer)

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  Date:

  	
   

  	
   

  
	
   

  	
  (Contracting
  Officer)

  	
   

  	
   

  	
   

  	
   

  
									

 

3

 

INVOICE/FINANCING REQUEST INSTRUCTIONS

FOR NIH COST-REIMBURSEMENT TYPE CONTRACTS, NIH(RC)-1

 

General: The contractor shall submit claims for reimbursement in the
manner and format described herein and as illustrated in the sample
invoice/financing request.

 

Format: Standard Form 1034, “Public Voucher for Purchases and Services
Other Than Personal,” and Standard Form 1035, “Public Voucher for Purchases and
Services Other Than Personal—Continuation Sheet,” or reproduced copies of such
forms marked ORIGINAL should be used to submit claims for reimbursement. In
lieu of SF-1034 and SF-1035, claims may be submitted on the payee’s letter-head
of self-designed form provided that it contains the information shown on the
sample invoice/financing request.

 

Number of Copies: As indicated in the Invoice
Submission Clause in the contract.

 

Frequency: Invoices/financing requests
submitted in accordance with the Payment Clause shall be submitted monthly
unless otherwise authorized by the contracting officer.

 

Cost Incurrence Period: Costs incurred must be within the
contract performance period or covered by precontract cost provisions.

 

Billing of Costs Incurred: If billed costs include: (1) costs
of a prior billing period, but not previously billed; or (2) costs incurred during
the contract period and claimed after the contract period has expired, the
amount and month(s) in which such costs were incurred shall be cited.

 

Contractor’s Fiscal Year: Invoices/financing requests shall
be prepared in such a manner that costs claimed can be identified with the
contractor’s fiscal year.

 

Currency: All NIH contracts are expressed in
United States dollars. When payments are made in a currency other than United
States dollars, billings on the contract shall be expressed, and payment by the
United States Government shall be made, in that other currency at amounts
coincident with actual costs incurred. Currency fluctuations may not be a basis
of gain or loss to the contractor. Notwithstanding the above, the total of all
invoices paid under this contract may not exceed the United States dollars
authorized.

 

Costs Requiring Prior Approval: Costs requiring the contracting
officer’s approval, which are not set forth in an Advance Understanding in the
contract shall be so identified and reference the Contracting Officer’s
Authorization (COA) Number. In addition, any cost set forth in an Advance
Understanding shall be shown as a separate line item on the request.

 

Invoice/Financing Request Identification: Each invoice/financing request
shall be identified as either:

 

(a)          Interim
Invoice/Contract Financing Request  — These are interim
payment requests submitted during the contract performance period.

 

(b)         Completion Invoice
— The completion
invoice is submitted promptly upon completion of the work; but no later than
one year from the contract completion date, or within 120 days after settlement
of the final indirect cost rates covering the year in which this contract is
physically complete (whichever date is later). The completion invoice should be
submitted when all costs have been assigned to the contract and all performance
provisions have been completed.

 

(c)          Final Invoice  —
A final invoice may be required after the amounts owed have been settled
between the Government and the contractor (e.g., resolution of all suspensions
and audit exceptions).

 

	
  NIH(RC)-1

  	
   

  	
   

  	
   

  	
  ATTACHMENT 3

  
	
  Rev. 5/97

  	
   

  	
   

  	
   

  	
   

  

 

1

 

Preparation and Itemization of the
Invoice/Financing Request: The contractor shall
furnish the information set forth in the explanatory notes below. These notes
are keyed to the entries on the sample invoice/financing request.

 

(a)          Designated
Billing Office Name and Address  —
Enter the designated billing office name and address, identified in the Invoice
Submission Clause of the contract, on all copies of the invoice/financing
request.

 

(b)         Invoice/Financing
Request Number  — Insert
the appropriate serial number of the invoice/financing request.

 

(c)          Date
Invoice/Financing Request Prepared — Insert the date the invoice/financing
request is prepared.

 

(d)         Contract
Number and Date — Insert the contract number and the effective date
of the contract.

 

(e)          Payee’s
Name and Address — Show the contractor’s name (as it appears in the
contract), correct address, and the title and phone number of the responsible
official to whom payment is to be sent. When an approved assignment has been
made by the contractor, or a different payee has been designated, then insert
the name and address of the payee instead of the contractor.

 

(f)            Total
Estimated Cost of Contract — Insert the total estimated cost of the
contract, exclusive of fixed-fee. For incrementally funded contracts, enter the
amount currently obligated and available for payment.

 

(g)         Total
Fixed-Fee — Insert the total fixed-fee (where applicable). For
incrementally funded contracts, enter the amount currently obligated and
available for payment.

 

(h)         Billing
Period — Insert the beginning and ending dates (month, day, and
year) of the period in which costs were incurred and for which reimbursement is
claimed.

 

(i)             Amount
Billed for Current Period — Insert the amount billed for the major
cost elements, adjustments, and adjusted amounts for the period.

 

(j)             Cumulative
Amount from Inception — Insert the cumulative amounts billed for the
major cost elements and adjusted amounts claimed during this contract.

 

(k)          Direct
Costs — Insert the major cost elements. For each element, consider
the application of the paragraph entitled “Costs Requiring Prior Approval” on
page 1 of these instructions.

 

(1)          Direct
Labor — Include salaries and wages paid (or accrued) for direct
performance of the contract.

 

(2)          Fringe
Benefits — List any fringe benefits applicable to direct labor and
billed as a direct cost. Fringe benefits included in indirect costs should not
be identified here.

 

(3)          Accountable
Personal Property — Include permanent research equipment and general
purpose equipment having a unit acquisition cost of $1,000 or more and having
an expected service life of more than two years, and sensitive property
regardless of cost (see the DHIIS Contractor’s
Guide for Control of Government Property). Show permanent research
equipment separate from general purpose equipment. Prepare and attach Form
HHS-565, “Report of Accountable Property,” in accordance with the following
instructions:

 

List each item for which reimbursement is requested. A reference shall
be made to the following (as applicable):

 

•                                          The
item number for the specific piece of equipment listed in the Property
Schedule.

 

2

 

•                                          The
COA letter and number, if the equipment is not covered by the Property
Schedule.

 

•                                          Be
preceded by an asterisk (*) if the equipment is below the approval level.

 

Further itemization of invoices/financing requests shall only be
required for items having specific limitations set forth in the contract.

 

(4)          Materials
and Supplies  — Include
equipment with unit costs of less than $1,000 or an expected service life of
two years or less, and consumable material and supplies regardless of amount.

 

(5)          Premium Pay
— List remuneration in excess of
the basic hourly rate.

 

(6)          Consultant
Fee  — List fees paid to
consultants. Identify consultant by name or category as set forth in the
contract’s advance understanding or in the COA letter, as well as the effort
(i.e., number of hours, days, etc.) and rate being billed.

 

(7)          Travel
— Include domestic and foreign
travel. Foreign travel is travel outside of Canada, the United States and its
territories and possessions. However, for an organization located outside
Canada, the United States and its territories and possessions, foreign travel
means travel outside that country. Foreign travel must be billed separately
from domestic travel.

 

(8)          Subcontract
Costs  — List
subcontractor(s) by name and amount billed.

 

(9)          Other
— List all other direct costs in
total unless exceeding $1,000 in amount. If over $1,000, list cost elements and
dollar amounts separately. If the contract contains restrictions on any cost
element, that cost element must be listed separately.

 

(l)             Cost of
Money (COM)  — Cite the
COM factor and base in effect during the time the cost was incurred and for
which reimbursement is claimed.

 

(m)       Indirect
Costs—Overhead  —
Identify the cost base, indirect cost rate, and amount billed for each indirect
cost category.

 

(n)         Fixed-Fee
Earned  — Cite the
formula or method of computation for the fixed-fee (if any). The fixed-fee must
be claimed as provided for by the contract.

 

(o)         Total
Amounts Claimed  —
Insert the total amounts claimed for the current and cumulative periods.

 

(p)         Adjustments
— Include amounts conceded by the
contractor, outstanding suspensions, and/or disapprovals subject to appeal.

 

(q)         Grand Totals

 

The contracting officer may require the
contractor to submit detailed support for costs claimed on one or more interim
invoices/financing requests.

 

3

 

SAMPLE INVOICE/FINANCING REQUEST

 

	
  (a)

  	
   

  	
  Billing Office Name and Address

  	
   

  	
  (b)

  	
   

  	
  Invoice/Financing Request No.

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  NATIONAL INSTITUTES OF HEALTH

  	
   

  	
                                                                                   

  
	
   

  	
   

  	
  National Cancer Institute, RCB

  	
   

  	
   

  
	
   

  	
   

  	
  EPS, Room

  	
   

  	
  (c)

  	
   

  	
  Date Invoice Prepared

  
	
   

  	
   

  	
  6120 EXECUTIVE BLVD MSC

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Bethesda, MD 20892-

  	
   

  	
                                                                                   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  (e)

  	
   

  	
  Payee’s Name and Address

  	
   

  	
  (d)

  	
   

  	
  Contract No. and Effective Date

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  ABC CORPORATION

  	
   

  	
                                                                                   

  
	
   

  	
   

  	
  100 Main Street

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Anywhere, U.S.A. zip code

  	
   

  	
  (f)

  	
   

  	
  Total Estimated Cost of Contract

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
                                                                                   

  
	
  Attention:

  	
   

  	
  Name, Title, and Phone Number

  	
   

  	
   

  
	
   

  	
   

  	
  of Official to Whom Payment is Sent

  	
   

  	
  (g)

  	
   

  	
  Total Fixed Fee

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
                                                                                   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  (h)

  	
   

  	
  This invoice/financing request represents reimbursable costs from
  Aug. 1, 1982 through Aug. 31, 1982

  
												

 

	
   

  	
   

  	
  (i) Amount
  Billed

  for Current Period

  	
   

  	
  (j)
  Cumulative Amount From Inception

  	
   

  
	
  (k)

  	
   

  	
  Direct Costs

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  (1)

  	
  Direct Labor

  	
   

  	
  $

  	
  3,400

  	
   

  	
  $

  	
  6,800

  	
   

  
	
   

  	
   

  	
  (2)

  	
  Fringe Benefits

  	
   

  	
  600

  	
   

  	
  1,200

  	
   

  
	
   

  	
   

  	
  (3)

  	
  Accountable Personal Property

  (Attach Form HHS-565)

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
  Permanent Research

  	
   

  	
  3,000

  	
   

  	
  6,000

  	
   

  
	
   

  	
   

  	
   

  	
  General Purpose

  	
   

  	
  2,000

  	
   

  	
  2,000

  	
   

  
	
   

  	
   

  	
  (4)

  	
  Materials and Supplies

  	
   

  	
  2,000

  	
   

  	
  4,000

  	
   

  
	
   

  	
   

  	
  (5)

  	
  Premium Pay

  	
   

  	
  100

  	
   

  	
  150

  	
   

  
	
   

  	
   

  	
  (6)

  	
  Consultant Fee-Dr. Jones 1 day @ 100 (COA
  #3)

  	
   

  	
  100

  	
   

  	
  100

  	
   

  
	
   

  	
   

  	
  (7)

  	
  Travel

  	
  (Domestic)

  	
   

  	
  200

  	
   

  	
  200

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  (Foreign)

  	
   

  	
  200

  	
   

  	
  200

  	
   

  
	
   

  	
   

  	
  (8)

  	
  Subcontract Costs

  	
   

  	
  -0-

  	
   

  	
  -0-

  	
   

  
	
   

  	
   

  	
  (9)

  	
  Other

  	
   

  	
  -0-

  	
   

  	
  -0-

  	
   

  
	
   

  	
   

  	
  Total Direct Costs

  	
   

  	
  $

  	
  11,600

  	
   

  	
  $

  	
  20,650

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  (j)

  	
   

  	
  Cost of Money (Factor) of (Approximate
  Base)

  	
   

  	
  2,400

  	
   

  	
  3,600

  	
   

  
	
  (m)

  	
   

  	
  Indirect Costs — Overhead 

              % of
  Direct Labor or Other Base (Formula)

  	
   

  	
  4,000

  	
   

  	
  6,000

  	
   

  
	
  (n)

  	
   

  	
  Fixed-Fee Earned (Formula)

  	
   

  	
  700

  	
   

  	
  1,400

  	
   

  
	
  (o)

  	
   

  	
  Total Amount Claimed

  	
   

  	
  $

  	
  18,700

  	
   

  	
  $

  	
  31,650

  	
   

  
	
  (p)

  	
   

  	
  Adjustments 

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
  Outstanding Suspensions

  	
   

  	
   

  	
   

  	
  (1,700

  	
  )

  
	
  (q)

  	
   

  	
  Grand Totals

  	
   

  	
   

  	
  $

  	
  18,700

  	
   

  	
  $

  	
  29,950

  	
   

  
														

 

“I certify that all payments requested are for appropriate purposes and
in accordance with the contract”.

 

	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  (Name of Official)

  	
   

  	
  (Title)

  

 

4

 

	
  National Institutes of Health

  	
   

  	
  Project Task

  	
   

  	
  Contract No.

  	
   

  	
  Date of Report

  
	
  FINANCIAL REPORT OF INDIVIDUAL

  PROJECT/CONTRACT, NIH FORM 2706

  	
   

  	
  Laboratory Support for Processing and Storage of Biomedical Specimens
  of Persons

  	
   

  	
  N02-CP-11001

  Contractor’s Name and Address

  	
   

  	
   

  	
   

  	
  0990-0134

  0990-0131

  
	
  Note: Complete this form in accordance with

  Accompanying Instructions.

  	
   

  	
  Reporting Period

  	
   

  	
  5107 Pegasus

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  Frederick, MD 21704

  	
   

  	
   

  	
   

  	
   

  

 

	
   

  	
   

  	
   

  	
   

  	
  Cumulative

  Incurred

  Cost at End
of Prior

  Period

  	
   

  	
  Incurred

  Cost-Curent

  Period

  	
   

  	
  Cumulative

  Cost to Date

  (D + E)

  	
   

  	
  Estimated

  Cost to

  Complete

  	
   

  	
  Estimated

  Cost at

  Completion

  (F + G)

  	
   

  	
  Negotiated

  Contract

  Amount

  	
   

  	
  Variance
  (Over

  or Under)

  (I - H)

  	
   

  
	
  Expenditure Category

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Percentage
  of Effort/Hours

  
	
  Negotiated

  	
   

  	
  Actual

  
	
  A

  	
   

  	
  B

  	
   

  	
  C

  	
   

  	
  D

  	
   

  	
  E

  	
   

  	
  F

  	
   

  	
  G

  	
   

  	
  H

  	
   

  	
  I

  	
   

  	
  J

  	
   

  
	
  Direct Labor

  	
   

  	
  139,205

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  $

  	
  2,560,213

  	
   

  	
   

  	
   

  
	
  Materials & Supplies

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  1,420,490

  	
   

  	
   

  	
   

  
	
  Travel

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  4,885

  	
   

  	
   

  	
   

  
	
  Equipment

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  1,228,197

  	
   

  	
   

  	
   

  
	
  Moving expenses

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  83,040

  	
   

  	
   

  	
   

  
	
  Other Direct Costs

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  339,762

  	
   

  	
   

  	
   

  
	
  Total Direct Costs:

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  $

  	
  5,636,587

  	
   

  	
   

  	
   

  
	
  Overhead

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  3,533,094

  	
   

  	
   

  	
   

  
	
  ?A

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  641,876

  	
   

  	
   

  	
   

  
	
  Total Proposed Cost:

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  $

  	
  9,811,558

  	
   

  	
   

  	
   

  
	
  [ILLEGIBLE] Fee

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  515,001

  	
   

  	
   

  	
   

  
	
  Total CPFF

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  $

  	
  10,326,558

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
																						

 

5

 

INSTRUCTIONS
FOR COMPLETING FORM NIH 2706

“FINANCIAL REPORT OF INDIVIDUAL PROJECT/CONTRACT”

 

GENERAL
INFORMATION

 

Purpose. Form NIH
2706 is designed to: (1) provide a management tool for use by use NIH in
monitoring the application of financial and personnel resources to the NIH contracts;
(2) provide contractors with financial and personnel management data which is
usable in their management processes; (3) promptly indicate potential areas of
contract underruns or overruns by making possible comparisons of actual
performance and projections with prior estimates on individual elements of cost
and personnel; and (4) obtain contractor’s analyses of cause and effect of
significant variations between actual and prior estimates of financial and
personnel performance.

 

REPORTING REQUIREMENTS

 

Scope. The specific
cost and personnel elements to be reported shall be established by mutual
agreement prior to award. The Government may require the contractor to provide
detailed documentation to support any elements(s) on one or more financial reports.

 

Number of Copies and Mailing Address. An
original and two (2) copies of the reports(s) shall be sent to the contracting
officer at the address shown on the face page of the contract, no later that 30
working days after the end of the period reported. However, the contract may
provide for one of the copies to be sent directly to the project officer.

 

REPORTING STATISTICS

 

A modification which extends the period of performance of an existing
contract will not require reporting on a separate Form NIH 2706, except where
it is determined by the contracting officer that separate reporting is
necessary. Furthermore, when incrementally funded contracts are involved, each
separate allotment is not considered a separate contract entity (only a funding
action). Therefore, the statistics under incrementally funded contracts should
be reported cumulatively from the inception of the contract through completion.

 

Definitions and Instructions for Completing
Form NIH 2706. For the purpose of establishing
expenditure categories in Column A, the following definitions and instructions
will be utilized. Each contract will specify the categories to be reported.

 

(1)               Key
Personnel. Include key personnel regardless of annual salary rates.
All such individuals should be listed by names and job titles on a separate
line including those whose salary is not directly charged to the contract but
whose effort is directly associated with the contract. The listing must be kept
up to date.

 

(2)               Personnel–Other.
List as one amount unless otherwise required by the contract.

 

(3)               Fringe
Benefits. Include allowances and services provided by the contractor
to employees as compensation in addition to regular salaries and wages. If a
fringe benefit rate(s) has been established, identify the base, rate, and
amount billed for each category. If a rate has not been established, the
various fringe benefit costs may be required to be shown separately. Fringe
benefits which are included in the indirect cost rate should not be shown here.

 

(4)               Accountable
Personal Property. Include nonexpendable personal property with an
acquisition cost of $1,000 or more and with an expected useful life of two of
more years, and sensitive items regardless of cost.

 

1

 

Form HHS 565, “Report of Accountable Property,” must accompany the
contractor’s public voucher (SF 1034/SF 1035) or this report if not previously
submitted. See “Contractor’s Guide for Control of Government Property.”

 

(5)               Supplies.
Include the cost of supplies and material and equipment charged directly to the
contract, but excludes the cost of nonexpendable equipment as defined in (4)
above.

 

(6)               Inpatient
Care. Includes costs associated with a subject while occupying a bed
in a patient care setting. It normally includes both routine and ancillary
costs.

 

(7)               Outpatient
Care. Include costs associated with a subject while not occupying a
bed. It normally includes ancillary costs only.

 

(8)               Travel.
Include all direct costs of travel, including transportation, subsistence and
miscellaneous expenses. Travel for staff and consultants shall be shown
separately. Identify foreign and domestic travel separately. If required by the
contract, the following information shall be submitted: (i) Name of traveler
and purpose of trip; (ii) Place of departure, destination and return, including
time and dates; and (iii) Total cost of trip.

 

(9)               Consultant
Fee. Include fees paid to consultant(s). Identify each consultant
with effort expended, billing rate, and amount billed.

 

(10)         Premium Pay.
Include the amount of salaries and wages over and above the basic rate of pay.

 

(11)         Subcontracts.
List each subcontract by name and amount billed.

 

(12)         Other Costs.
Include any expenditure categories for which the Government does not require
individual line item reporting. It may include some of the above categories.

 

(13)         Overhead/Indirect
Costs. Identify the cost base, indirect cost rate, and amount billed
for each indirect cost category.

 

(14)         General and
Administrative Expenses. Cite the rate and the base. In the case of
nonprofit organizations, this item will usually be included in the indirect
cost.

 

(15)         Fee.
Cite the fee earned, if any.

 

(16)         Total Costs
to the Government.

 

PREPARATION INSTRUCTIONS

 

These instructions are keyed to the Columns on Form NIH 2706.

 

Column A—Expenditure Category.
Enter the expenditure categories required by the contract.

 

Column B—Percentage of Effort/Hours
Negotiated. Enter the percentage of effort or number
of hours agreed to during contract negotiations for each labor category listed
in Column A.

 

Column C—Percentage of Effort/Hours-Actual.
Enter the cumulative percentage of effort or number of hours worked by each
employee or group of employees listed in Column A.

 

Column D—Cumulative Incurred Cost at End of
Prior Period. Enter the cumulative incurred costs up
to the

 

2

 

end of the prior reporting period. This column will be blank at the
time of the submission of the initial report.

 

Column E—Incurred Cost-Current Period.
Enter the costs which were incurred during the current period.

 

Column F—Cumulative Incurred Cost to Date.
Enter the combined total of Columns D and E.

 

Column G—Estimated Cost to Complete.
Make entries only when the contractor estimates that a particular expenditure
category will vary from the amount negotiated. Realistic estimates are
essential.

 

Column H—Estimated Costs at Completion.
Complete only if an entry is made in Column G.

 

Column I—Negotiated Contract Amount.
Enter in this column the costs agreed to during contract negotiations for all
expenditure categories listed in Column A.

 

Column J—Variance (Over or Under).
Complete only if an entry is made in Column H. When entries have been made in
Column H, this column should show the difference between the estimated costs at
completion (Column H) and negotiated costs (Column I). When a line item varies
by plus or minus 10 percent, i.e., the percentage arrived at by dividing Column
J by Column I, an explanation of the variance should be submitted. In the case
of an overrun (net negative variance), this submission shall not be deemed as
notice under the Limitation of Cost (Funds) Clause of the contract.

 

Modifications. List
any modification in the amount negotiated for an item since the preceding
report in the appropriate cost category.

 

Expenditures Not Negotiated.
List any expenditure for an item for which no amount was negotiated (e.g., at
the discretion of the contractor in performance of its contract) in the
appropriate cost category and complete all columns except for I. Column J will
of course show a 100 percent variance and will be explained along with those
identified under J above.

 

3

 

PRIVACY ACT SYSTEM OF RECORDS

 

[Federal Register: April 7, 1997 (Volume
62, Number 66)]

[Notices]

[Page 16596-16602]

From the Federal Register Online via GPO
Access [wais. access.gpo.gov]

[DOCID:fr07ap97_dat-89]

 

 

[[Page 16596]]

 

DEPARTMENT OF HEALTH AND HUMAN SERVICES

 

National Institutes of Health

 

 

Privacy Act of 1974; New System of Records

 

agency: National Institutes of Health, HHS.

 

action: Notification of a new system of
records.

 

 

summary: In accordance with the requirements
of the Privacy Act, the National Institutes of Health (NIH) is publishing a
notice of a new system of records, 09-25-0200, “Clinical, Epidemiologic and
Biometric Studies of the National Institutes of Health (NIH), HHS/NIH/OD.” This
system notice serves as an umbrella system for most NIH clinical, epidemiologic
and biometric research studies. 
Thirty-eight existing NIH system notices were subsumed under this notice
(listed in the system notice under System Manager(s)), to reduce the number and
avoid future proliferation of like system notices.  We are also proposing routine uses for this new system; with two
exceptions, these routine uses were already contained in the preceding system
notices.  The first new routine use will
allow disclosure to authorized organizations which provide health services to
subject individuals or provide third-party reimbursement or fiscal intermediary
functions.  The purpose of the
disclosure is to plan for or provide such services, bill or collect third-party
reimbursements.  The second new routine
use will allow disclosure for the purpose of reporting child, elder, or spousal
abuse or neglect, or any other type of abuse or neglect as required by State or
Federal law.

 

dates: NIH invites interested parties to
submit comments on the proposed internal and routine uses on or before May 7,
1997.  NIH has sent a report of a New
System to the Congress and to the Office of Management and Budget (OMB) on
November 6, 1996.  This system of
records will be effective 40 days from the date of publication unless NIH

 

1

 

receives comments on the routine uses which
would result in a contrary determination.

 

address: Please submit comments to: NIH
Privacy Act Officer, Building 31, Room 1BO5, 31 Center Drive MSC 2075,
Bethesda, MD 20892-2075, 301-496-2832.

Comments received will be available for
inspection at this same address from 9 a.m. to 3 p.m., Monday through Friday.

 

for further information contact: NIH Privacy
Act Officer, Building 31, Room 1B05, 31 Center Drive MSC 2075, Bethesda, MD
20892-2075, 301-496-2832.

The numbers listed above are not toll free.

 

supplementary information:  The National Institutes of Health (NIH)
proposes to establish a new system of records: 09-25-0200, “Clinical,
Epidemiologic and Biometric Studies of the National Institutes of Health (NIH),
HHS/NIH/OD.” This umbrella system of records will be used by NIH staff to
document, track, monitor and evaluate NIH clinical, epidemiologic and biometric
research activities.  This inclusive
system notice will achieve agency administrative efficiencies, avoiding
confusion created by the current fragmented pool of Institute, Center and
Division (ICD) system notices.  Because
of its unique organizational structure, NIH has, over the recent decades,
experienced a proliferation of almost identical system notices that differ only
by disease/disorder under study or ICD interest.  This system notice subsumes thirty-eight existing system notices
and will offer coverage for research not currently covered by an appropriate system
notice.  The consolidation of similar
research systems of records into one generic type notice will also serve the
public interest.  It will alleviate
burden on the public associated with multiple attempts at notification, access
and correction of record information when individuals are not sure which
research system notice applied to their study participation.

The system will comprise records about
individuals as relevant to a particular research study.  Examples include, but are not limited to:
Name, study identification number, address, relevant telephone numbers, Social
Security Number (voluntary), driver’s license number, date of birth, weight,
height, sex, race; medical, psychological and dental information, laboratory
and diagnostic testing results; registries; social, economic and demographic
data; health services utilization; insurance and hospital cost data, employers,
conditions of the work environment, exposure to hazardous substances/compounds;
information pertaining to stored biologic specimens (including blood, urine,
tissue and genetic materials), characteristics and activities of health care
providers and educators and trainers (including curriculum vitae); and
associated correspondence.  The amount
of information recorded on each individual will be only that which is necessary
to accomplish the purpose of the system.

The records in this system will be maintained
in a secure manner compatible with their content and use.  NIH and contractor staff will be required to
adhere to the provisions of the Privacy Act and the HHS Privacy Act
Regulations.  The System Manager will
control access to the

 

2

 

data. 
Only authorized users whose official duties require the use of such
information will have regular access to the records in this system.  Authorized users are HHS employees, and
contractors responsible for implementing the research.

Records may be stored on index cards, file
folders, computer tapes and disks (including optical disks), photography media,
microfiche, microfilm, and audio and video tapes.  Manual and computerized records will be maintained in accordance
with the standards of Chapter 45-13 of the HHS General Administration Manual,
“Safeguarding Records Contained in Systems of Records,” supplementary Chapter
PHS hf:45-13, the Department’s Automated Information System Security Program
Handbook, and the National Institute of Standards and Technology Federal
Information Processing Standards (FIPS Pub. 41 and FIPS Pub. 31).

Data on computer files is accessed by keyword
known only to authorized users.  Access
to information is thus limited to those with a need to know.  Rooms where records are stored are locked
when not in use.  During regular
business hours rooms are unlocked but are controlled by on-site personnel.  Researchers authorized to conduct research
on biological specimens will typically access to the system through the use of
encrypted identifiers sufficient to link individuals with records in such a
manner that does not compromise confidentiality of the individual.  All authorized users of personal information
in connection with the performance of their jobs protect information from
public view and from unauthorized personnel entering an unsupervised
office.  Depending upon the sensitivity
of the information in the record, additional safeguard measures are employed.

The routine uses proposed for this system are
compatible with the stated purposes of the system. The first routine use
permits disclosure of a record for an authorized research purpose under
specified conditions.  The second
routine use permitting disclosure to a congressional office is proposed to
allow subject individuals to obtain assistance from their representatives in
Congress, should they so desire. Such

 

[[Page 16597]]

 

disclosure would be made only pursuant to a
request of the individual. The third routine use allows disclosure to the
Department of Justice for use in litigation. 
The fourth routine use allows disclosure of records to contractor,
grantee, experts, consultants or volunteers who have been engaged by the agency
to assist in the performance of a service related to this system of records and
who need to have access to the records in order to perform the activity.  The fifth routine use allows disclosure to
certain relevant third parties (e.g., relatives, prior employees, Motor Vehicle
Administration, State vita statistics offices) when necessary to obtain
information on morbidity and mortality experiences and to locate individuals
for follow-up studies.  The sixth
routine use allows disclosure to tumor registries for maintenance of health
statistics.  The seventh routine use
allows the PHS to inform the sexual and/or needle-sharing partner(s) of a
subject individual who is infected with the human immunodeficiency virus (HIV)
of their exposure to HIV, or to disclose such information to State or local
public health departments under specified circumstances. The

 

3

 

eighth routine use allows disclosure of
certain diseases and conditions, including infectious diseases, to appropriate
representatives of State or Federal Government as required by State or Federal
law.  The ninth routine use allows
records to be disclosed to authorized organizations which provide health
services to subject individuals or provide third-party reimbursement or fiscal
intermediary functions, for the purpose of planning for or providing such
services, billing or collecting third-party reimbursements.  The tenth routine use allows disclosure to
organizations deemed qualified by the Secretary, DHHS, to carry out quality
assessment, medical audits or utilization reviews.  The eleventh routine use allows information to be disclosed for
the purpose of reporting child, elder or spousal abuse or neglect, or any other
type of abuse or neglect as required by State or Federal law.

The following notice is written in the
present, rather than future tense, in order to avoid the unnecessary
expenditure of public funds to republish the notice after the system has become
effective.

 

Dated: October 30, 1996.

Anthony L. Itte?lag,

Deputy Director for Management, National
Institutes of Health.

09-25-0200

 

SYSTEM NAME:

Clinical, Epidemiologic and Biometric Studies
of the National Institutes of Health (NIH), HHS/NIH/OD.

 

SECURITY CLASSIFICATION:

None.

 

SYSTEM LOCATION:

Records are located at NIH and Contractor
research facilities which collect or provide research data for this
system.  Contractors may include, but
are not limited to: Research centers, clinics, hospitals, universities, medical
schools, research institutions/foundations, national associations, commercial
organizations, collaborating State and Federal Government agencies, and
coordinating centers.  A current list of
sites, including the address of any Federal Records Center where records from
this system may be stored, is available by writing to the appropriate
Coordinator listed under Notification Procedure.

 

CATEGORIES OF INDIVIDUALS COVERED BY THE
SYSTEM:

Adults and/or children who are the subjects
of clinical, epidemiologic, and biometric research studies of the NIH.  Individuals with disease.  Individuals who are representative of the
general population or of special groups including, but not limited to: Normal
controls, normal volunteers, family members and relatives; providers of services
(e.g., health care and social work); health care professionals and educators,
and demographic sub-groups as applicable, such as age, sex, ethnicity, race,
occupation, geographic location; and groups exposed to real and/or hypothesized
risks (e.g., exposure to biohazardous microbial agents).

 

4

 

CATEGORIES OF RECORDS IN THE SYSTEM:

The system contains data about individuals as
relevant to a particular research study. Examples include, but are not limited
to: Name, study identification number, address, relevant telephone numbers,
Social Security Number (voluntary), driver’s license number, date of birth,
weight, height, sex, race; medical, psychological and dental information,
laboratory and diagnostic testing results; registries; social, economic and
demographic data; health services utilization; insurance and hospital cost
data, employers, conditions of the work environment, exposure to hazardous
substances/compounds; information pertaining to stored biologic specimens
(including blood, urine, tissue and genetic materials), characteristics and
activities of health care providers and educators and trainers (including
curriculum vitae); and associated correspondence.

 

AUTHORITY FOR MAINTENANCE OF THE SYSTEM:

“Research and Investigation,” “Appointment
and Authority of the Directors of the National Research Institutes,” “National
Cancer Institute,” “National Eye Institute,” “National Heart, Lung and
Blood-Institute,” “National Institute on Aging,” “National Institute on Alcohol
Abuse and Alcoholism,” “National Institute on Allergy and Infectious Diseases,”
“National Institute of Arthritis and Musculoskeletal and Skin Diseases,” “
National Institute of Child Health and Human Development,” “National Institute
on Deafness and Other Communication Disorders,” “National Institute of Dental
Research,” “National Institute of Diabetes, and Digestive and Kidney Diseases,”
“National Institute of Drug Abuse,” “National Institute of Environmental Health
Sciences,” “National Institute of Mental Health,” “National Institute of
Neurological Disorders and Stroke,” and the “National Center for Human Genome
Research,” of the Public Health Service Act. (42 U.S.C. 241, 242, 248, 281,
282, 284, 285a, 285b, 285c, 285d, 285e, 285f, 285g, 285h, 285i, 285j, 285l,
285m, 285n, 285o, 285p, 285q, 287, 287b, 287c, 289a, 289c, and 44 U.S.C. 3101.)

 

PURPOSE(S)

To document, track, monitor and evaluate NIH
clinical, epidemiologic and biometric research activities.

 

ROUTINE USES OF RECORDS MAINTAINED IN THE
SYSTEM, INCLUDING CATEGORIES OF USERS AND THE PURPOSES OF SUCH USES:

1. A record may be disclosed for a research purpose, when the
Department: (A) has determined that the use or disclosure does not violate
legal or policy limitations under which the record was provided, collected, or
obtained; e.g., disclosure of alcohol or drug abuse patient records will be
made only in accordance with the restrictions of confidentiality statutes and
regulations 42 U.S.C. 241, 42 U.S.C. 290dd-2, 42 CFR part 2, and where
applicable, no disclosures will be made inconsistent with an authorization of
confidentiality under 42 U.S.C. 241 and 42 CFR part 2a; (B) has determined that
the research purpose (1) cannot be reasonably accomplished unless the

 

[[Page
16598]]

 

5

 

record is provided in individually
identifiable form, and (2) warrants the risk to the privacy of the individual
that additional exposure of the record might bring; (C) has required the
recipient to (1) establish reasonable administrative, technical, and physical
safeguards to prevent unauthorized use or disclosure of the record, (2) remove
or destroy the information that identifies the individual at the earliest time
at which removal or destruction can be accomplished consistent with the purpose
of the research project, unless the recipient has presented adequate
justification of a research or health nature for retaining such information,
and (3) make no further use or disclosure of the record except (a) in emergency
circumstances affecting the health or safety of any individual, (b) for use in
another research project, under these same conditions, and with written
authorization of the Department, (c) for disclosure to a property identified
person for the purpose of an audit related to the research project, if
information that would enable research subjects to be identified is removed or
destroyed at the earliest opportunity consistent with the purpose of the audit,
or (d) when required by law; and (D) has secured a written statement attesting
to the recipient’s understanding of, and willingness to abide by, these
provisions.

2. Disclosure may be made to a Member of Congress or to a
Congressional staff member in response to an inquiry of the Congressional
office made at the written request of the constituent about whom the record is
maintained.

3. The Department of Health and Human
Services (HHS) may disclose information from this system of records to the
Department of Justice when; (a) The agency or any component thereof; or (b) any
employee of the agency in his or her official capacity where the Department of
Justice has agreed to represent the employee: or (c) the United States
Government, is a party to litigation or has an interest in such litigation, and
by careful review, the agency determines that the records are both relevant and
necessary to the litigation and the use of such records by the Department of
Justice is therefore deemed by the agency to be for a purpose that is
compatible with the purpose for which the agency collected the records.

4. Disclosure may be made to agency
contractors, grantees, experts, consultants, collaborating researchers, or
volunteers who have been engaged by the agency to assist in the performance of
a service related to this system of records and who need to have access to the
records in order to perform the activity. Recipients shall be required to
comply with the requirements of the Privacy Act of 1974, as amended, pursuant
to 5 U.S.C. 552a(m).

5. Information from this system may be
disclosed to Federal agencies, State agencies (including the Motor Vehicle
Administration and State vital statistics offices, private agencies, and other
third parties (such as current or prior employers, acquaintances, relatives),
when necessary to obtain information on morbidity and mortality experiences and
to locate individuals for follow-up studies. Social Security numbers, date of
birth and other identifiers may be disclosed: (1) To the National Center for
Health Statistics to ascertain vital status through the National Death Index;
(2) to the Health Care Financing Agency to ascertain morbidities; and (3) to
the Social Security Administration to ascertain disabilities and/or location of

 

6

 

participants.  Social Security numbers may also be given to other Federal
agencies, and State and local agencies when necessary to locating individuals
for participation in follow-up studies.

6. 
Medical information may be disclosed in identifiable form to tumor registries
for maintenance of health statistics, e.g., for use in epidemiologic studies.

7. 
(a).  PHS may inform the sexual
and/or needle-sharing partner(s) of a subject individual who is infected with
the human immunodeficiency virus (HIV) of their exposure to HIV, under the
following circumstances: (1) The information has been obtained in the course of
clinical activities at PHS facilities carried out by PHS personnel or
contractors; (2) the PHS employee or contractor has made reasonable efforts to
counsel and encourage the subject individual to provide the information to the
individual’s sexual or needle-sharing partner(s); (3) The PHS employee or
contractor determines that the subject individual is unlikely to provide the
information to the sexual or needle-sharing partner(s) or that the provision of
such information cannot reasonably be verified; and (4) The notification of the
partner(s) is made, whenever possible, by the subject individual’s physician or
by a professional counselor and shall follow standard counseling practices.

(b). 
PHS may disclose information to State or local public health
departments, to assist in the notification of the subject individual’s sexual
and/or needle-sharing partner(s), or in the verification that the subject
individual has notified such sexual or needle-sharing partner(s).

8. 
Certain diseases and conditions, including infectious diseases, may be
reported to appropriate representatives of State or Federal Government as
required by State or Federal law.

9. 
Disclosure may be made to authorized organizations which provide health
services to subject individuals or provide third-party reimbursement or fiscal
intermediary functions, for the purpose of planning for or providing such
services, billing or collecting third-party reimbursements.

10. 
The Secretary may disclose information to organizations deemed qualified
to carry out quality assessment, medical audits or utilization reviews.

11. 
Disclosure may be made for the purpose of reporting child, elder or
spousal abuse or neglect or any other type of abuse or neglect as required by
State or Federal law.

 

POLICIES AND PRACTICES FOR STORING,
RETRIEVING, ACCESSING, RETAINING, AND DISPOSING OF RECORDS IN THE SYSTEM:

STORAGE:

Records may be stored on index cards, file
folders, computer tapes and disks (including optical disks), photography media,
microfiche, microfilm, and audio and video tapes.  For certain studies, factual data with study code numbers are
stored on computer tape or disk, while the key to personal identifiers is stored
separately, without factual data, in paper/computer files.

 

RETRIEVABILITY:

During data collection stages and follow-up,
retrieval is by

 

7

 

personal identifier (e.g., name, Social
Security Number, medical record or study identification number, etc.).  During the data analysis stage, data are
normally retrieved by the variables of interest (e.g., diagnosis, age,
occupation).

 

SAFEGUARDS:

1. 
Authorized Users:  Access to
identifiers and to link files is strictly limited to the authorized personnel
whose duties require such access. 
Procedures for determining authorized access to identified data are
established as appropriate for each location. 
Personnel, including contractor personnel, who may be so authorized
include those directly involved in data collection and in the design of
research studies, e.g., interviewers and interviewer supervisors; project
managers; and statisticians involved in designing sampling plans.  Other one-time and special access by other
employees is granted on a need-to-know basis as specifically authorized by the
system manager.

 

[[Page 16599]]

 

Researchers authorized to conduct research on
biologic specimens will typically access the system through the use of
encrypted identifiers sufficient to link individuals with records in such a
manner that does not compromise confidentiality of the individual.

2. 
Physical Safeguards:  Records are
either stored in locked rooms during off-duty hours, locked file cabinets,
and/or secured computer facilities.  For
certain studies, personal identifiers and link files are separated and stored
in locked files.  Computer data access
is limited through the use of key words known only to authorized personnel.

3. 
Procedural Safeguards: 
Collection and maintenance of data is consistent with legislation and
regulations in the protection of human subjects, informed consent,
confidentially, and confidentiality specific to drug and alcohol abuse patients
where these apply.  When anonymous data
is provided to research scientists for analysis, study numbers which can be
matched to personal identifiers will be eliminated, scrambled, or replaced by
the agency or contractor with random numbers which cannot be matched.  Contractors who maintain records in this system
are instructed to make no further disclosure of the records.  Privacy Act requirements are specifically
included in contracts fro survey and research activities related to this
system.  The OHS project directors,
contract officers, and project officers oversee compliance with these
requirements.  Personnel having access
are trained in Privacy Act requirements. 
Depending upon the sensitivity of the information in the record,
additional safeguard measures may be employed.

4. 
Implementation Guidelines: DHHS Chapter 45-13 and supplementary Chapter
PHS.hf: 45-13 of the HHS General Administration Manual and Part 6, “ADP System
Security” of the HHS ADP Systems Security Manual.

 

RETENTION AND DISPOSAL:

Records are retained and disposed of under
the authority of the NIH Records Control Schedule contained in NIH Manual
Chapter 1743, Appendix 1 — “Keeping and Destroying Records” (HHS Records
Management Manual,

 

8

 

Appendix B-361), item 3000-G-3, which allows
records to be kept as long as they are useful in scientific research.  Collaborative Perinatal Project records are
retained in accordance with item 3000-G-4, which does not allow records to be
destroyed.  William A. White Clinical
Research Program medical records (Saint Elizabeths Hospital, NIMH) are retained
for 5 years after last discharge or upon death of a patient and then
transferred to the Washington National Records Center, where they are retained
until 30 years after discharge or death. 
Refer to the NIH Manual Chapter for specific conditions on disposal or
retention instructions.

 

SYSTEM MANAGER(S) AND ADDRESS:

See Appendix 1 for a listing of current
system managers.  This system is for use
by all NIH Institutes, Centers, and Divisions. 
The following system notices have been subsumed under this umbrella
system notice.

 

09-25-0001 Clinical Research: Patient
Records, HHS/NIH/NHLBI

09-25-0010 Research Resources: Registry of
Individuals Potentially Exposed to Microbial Agents, HHS/NIH/NCI

09-25-0015 Clinical Research: Collaborative
Clinical Epilepsy Research, HHS/NIH/NINDS

09-25-0016 Clinical Research: Collaborative
Perinatal Project, HHS/NIH/NINDS

09-25-0026 Clinical Research: Nervous System
Studies, HHS/NIH/NINDS

09-25-0028 Clinical Research: Patient Medical
Histories, HHS/NIH/NINDS and HHS/NIH/NIDCD

09-25-0031 Clinical Research: Serological and
Virus Data in Studies Related to the Central Nervous System, HHS/NIH/NINDS

09-25-0037 Clinical Research: The Baltimore
Longitudinal Study of Aging, HHS/NIH/NIA

09-25-0038 Clinical Research: Patient Data,
HHS/NIH/NIDDK

09-25-0039 Clinical Research: Diabetes
Mellitus Research Study of Southwestern American Indians, HHS/NIH/NIDDK

09-25-0040 Clinical Research: Southwestern
American Indian Patient Data, HHS/NIH/ NIDDK

09-25-0042 Clinical Research: National
Institute of Dental Research Patient Records, HHS/NIH/NIDR

09-25-0044 Clinical Research: Sensory Testing
Research Program, HHS/NIH/ NIDR

09-25-0046 Clinical Research: Catalog of
Clinical Specimens from Patients, Volunteers and Laboratory Personnel,
HHS/NIH/NIAID

09-25-0053 Clinical Research: Vision Studies,
HHS/NIH/NEI

09-25-0057 Clinical Research: Burkitt’s
Lymphonma Registry, HHS/NIH/NCI

09-25-0060 Clinical Research: Division of
Cancer Treatment Clinical Investigations, HHS/NIH/NCI

09-25-0067 Clinical Research: National Cancer
Incidence Surveys, HHS/NIH/NCI

09-25-0069 NIH Clinical Center Admissions of
the National Cancer Institute, HHS/NIH/NCI

09-25-0074 Clinical Research: Division of
Cancer Biology and Diagnosis Patient Trials, HHS/NIH/NCI

 

9

 

09-25-0077 Biological Carcinogenesis Branch
Human Specimen Program, HHS/NIH/NCI

09-25-0126 Clinical Research: National Heart,
Lung, and Blood Institute Epidemiological and Biometric Studies, HHS/NIH/NHLBI

09-25-0128 Clinical Research: Neural
Prosthesis and Biomedical Engineering Studies, HHS/NIH/NINDS

09-25-0129 Clinical Research: Clinical
Research Studies Dealing with Hearing, Speech, Language and Chemosensory
Disorders, HHS/NIH/NIDCD

09-25-0130 Clinical Research: Studies in the
Division of Cancer Cause and Prevention, HHS/NIH/NCI

09-25-0134 Clinical Research: Epidemiology
Studies, National Institute of Environmental Health Sciences , HHS/NIH/NIEHS

09-25-0142 Clinical Research: Records of
Subjects in Intramural Research, Epidemiology, Demography and Biometry Studies
on Aging, HHS/NIH/NIA

09-25-0143 Biomedical Research: Records of
Subjects in Clinical, Epidemiologic and Biometric Studies of the National
Institute of Allergy and Infectious Diseases, HHS/NIH/NIAID

09-25-0145 Clinical Trials and
Epidemiological Studies Dealing with Visual Disease and Disorders in the
National Eye Institute, HHS/NIH/NEI

09-25-0148 Contracted and Contract-Related
Research: Records of Subjects in Clinical, Epidemiological and Biomedical
Studies of the National Institute of Neurological Disorders and Stroke and the
National Institute on Deafness and Other Communication Disorders, HHS/NIH/NINDS
and HHS/NIH/NIDCD

09-25-0152 Biomedical Research: Records of
Subjects in National Institute of Dental Research Contracted Epidemiological
and Biometric Studies, HHS/NIH/NIDR

09-25-0153 Biomedical Research: Records of
Subjects in Biomedical and Behavioral Studies of Child Health and Human
Development, HHS/NIH/NICHD

09-25-0154 Biomedical Research: Records of
Subjects: 1) Cancer Studies of the Division of Cancer Prevention and Control,
HHS/NIH/NCI; and 2) Women’s Health Initiative (WHI) Studies , HHS/NIH/OD

09-25-0170 Diabetes Control and Complications
Trial (DCCT) DataSystem, HHS/NIH/NIDDK

09-25-0172 Clinical Research: National Center
for Human Genome Research, HHS/NIH/NCHGR

09-25-0201 Clinical Research: National
Institute of Mental Health Patient Records, HHS/NIH/NIMH

09-25-0205 Alcohol, Drug Abuse, and Mental
Health Epidemiologic and Biometric Research Data, HHS/NIH/NIAAA, HHS/NIH/NIDA
and HHS/NIH/NIMH

09-25-0212 Clinical Research: Neuroscience
Research Center Patient Medical Records, HHS/NIH/NIMH

 

[[Page 16600]]

 

NOTIFICATION PROCEDURE:

To determine if a record exists, write to the
appropriate ICD Privacy Act Coordinator listed below.  In cases where the requestor

 

10

 

knows specifically which System Manager to
contact, he or she may contact the System Manager directly (See Appendix
I).  Notification requests should
include: Individual’s name; current address; date of birth; date, place and
nature of participation in specific research study; name of individual or
organization administering the research study (if known); name or description
of the research study (if known); address at the time of participation; and in
specific cases, a notarized statement (some highly sensitive systems require
two witnesses attesting to the individual’s identity).  A requestor must verify his or her identity
by providing either a notarization of the request  or by submitting a written certification that the requestor is
who he or she claims to be and understands that the knowing and willful request
for acquisition of a record pertaining to an individual under false pretenses
is a criminal offense under the Act, subject to a five thousand dollar fine.

Individuals will be granted direct access to
their medical records unless the System Manager determines that such access is
likely to have an adverse effect (i.e., could cause harm) on the
individual.  In such cases when the
System Manager has determined that the nature of the record information
requires medical interpretation, the subject of the record shall be requested
to designate, in writing, a responsible representative who will be willing to
review the record and inform the subject individual of its contents at the
representative’s discretion.  The
representative may be a physician, other health professional, or other
responsible individual.  In this case,
the medical/dental record will be sent to the designated representative.  Individuals will be informed in writing if
the record is sent to the representative. 
This same procedure will apply in cases where a parent or guardian
requests notification of, or access to, a child’s or incompetent person’s
medical record.  The parent or guardian
must also verify (provide adequate documentation) their relationship to the
child or incompetent person as well as his or her own identity to prove their
relationship.

If the requester does not know which
Institute, Center or Division Privacy Act Coordinator to contact for
notification purposes, he or she may contact directly the NIH Privacy Act
Officer at the following address: NIH Privacy Act Officer, Office of Management
Assessment, Building 31, Room 1B05, 31 Center Drive MSC 2075, Bethesda, MD
20892-2075.

 

NIH Privacy Act Coordinators

 

Office of the Director, (OD), NIH

Associate Director for Disease Prevention,
OD, NIH

Building 1, Room 260

1 Center Drive

Bethesda, MD 20892

National Cancer Institute (NCI)

Privacy Act Coordinator, NCI, NIH

Building 31, Room 10A34

31 Center Drive

Bethesda, MD 20892

National Eye Institute (NEI)

Privacy Act Coordinator, NEI, NIH

 

11

 

Building 31, Room 6A-19

31 Center Drive

Bethesda, MD 20892

National Heart, Lung and Blood Institute
(NHLBI)

Privacy Act Coordinator, NHLBI, NIH

Building 31, Room 5A08

31 Center Drive

Bethesda, MD 20892

National Institute on Aging (NIA)

Privacy Act Coordinator, NIA, NIH

Building 31, Room 2C12

31 Center Drive

Bethesda, MD 20892

National Institute on Alcohol Abuse and
Alcoholism (NIAAA)

Privacy Act Coordinator, NIAAA, NIH

Wilco Building, Suite

6000 Executive Blvd., MSC 7003

Bethesda, MD 20892-7003

National Institute of Allergy and Infectious
Diseases (NIAID)

Privacy Act Coordinator, NIAID, NIH

Solar Building, Room 3C-23

6003 Executive Blvd.

Bethesda, MD 20892

National Institute of Arthritis and
Musculoskeletal and Skin

Diseases (NIAMS)

Privacy Act Coordinator, NIAMS, NIH

Natcher Building, Room SQS49

45 Center Drive

Bethesda, MD 20892

National Institute of Child Health and Human
Development (NICHD)

Privacy Act Coordinator, NICHD, NIH

6100 Executive Blvd., Room 5D01

North Bethesda, MD 20892

National Institute on Deafness and Other
Communication Disorders (NIDCD)

Privacy Act Coordinator, NIDCD, NIH

Building 31, Room 3C02

9000 Rockville Pike

Bethesda, MD 20892

National Institute of Dental Research (NIDR)

Privacy Act Coordinator, NIDR, NIH

Building 31, Room 2C-35

31 Center Drive, MSC 2290

Bethesda, MD 20892-2290

National Institute of Diabetes and Digestive
and Kidney Disease

(NIDDK)

Privacy Act Coordinator, NIDDK, NIH

Building 31, Room 9A47

31 Center Drive

Bethesda, MD 20892

National Institute of Drug Abuse (NIDA)

Privacy Act Coordinator, NIDA, NIH

Parklawn Building, Room 10A-42

 

12

 

5600 Fishers Lane

Rockville, Maryland 20857

National Institute of Environmental Health
Sciences (NIEHS)

Chief, Epidemiology Branch, NIEHS, NIH

P.O. Box 12233

Research Triangle Park

North Carolina 27709

National Institute of Mental Health (NIMH)

Privacy Act Coordinator, NIMH, NIH

Parklawn Building, Room 7C-22

5600 Fishers Lane

Rockville, Maryland 20857

National Institute of Neurological Disorders
and Stroke (NINDS)

Privacy Act Coordinator, NINDS, NIH

Federal Building, Room 816

7550 Wisconsin Avenue

Bethesda, MD 20892

National Center for Human Genome Research
(NCHGR)

Chief, Office of Human Genome Communications,
NGHGR, NIH

Building 38A, Room 617

9000 Rockville Pike

Bethesda, Maryland 20892

 

RECORD ACCESS PROCEDURE:

Same as notification procedures.  Requesters should reasonably specify the
record contents being sought.  An
individual may also request an accounting of disclosures of his/her record, if
any.

 

CONTESTING RECORD PROCEDURE:

Contact the appropriate official at the
address specified under Notification Procedure, and reasonably identify the
record, specify the information being contested, and state  corrective action sought, with supporting
information to show how the record is inaccurate, incomplete, untimely, or
irrelevant.

 

RECORD SOURCE CATEGORIES:

The system contains information obtained
directly from the subject individual by interview (face-to-face or telephone),
written questionnaire, or by other tests, recording devices or observations,
consistent with legislation and regulation regarding informed consent and
protection of human subjects. 
Information is also obtained from other sources, including but not
limited to: Referring medical physicians, mental health/alcohol/drug abuse or
other health care providers; hospitals; organizations providing biological
specimens; relatives; guardians; schools; and clinical medical research
records.

 

SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS OF
THE ACT:

None.

 

Appendix I: System Managers and Addresses

 

Office of the Director, NIH

 

13

 

[[Page 16601]]

 

Associate Director for Disease Prevention,
OD, NIH

Building 1, Room 260

1 Center Drive

Bethesda, MD 20892

 

National Cancer Institute

Computer Systems Analyst, DCBD, NCI, NIH

Executive Plaza North, Room 344

Bethesda, MD 20892

 

American Burkitt’s Lymphoma Registry

Division of Cancer Etiology, NCI, NIH

Executive Plaza North, Suite 434

6130 Executive Blvd.

Bethesda, MD 20892

 

Chief, Genetic Epidemiology Branch, EBP, DCE,
NCI, NIH

Executive Plaza North, Suite 439

6130 Executive Blvd.

Bethesda, MD 20892

 

Chief, Clinical Genetics Section

Clinical Epidemiology Branch, DCE, NCI, NIH

Executive Plaza North, Suite 400

6130 Executive Blvd.

Bethesda, MD 20892

 

Program Director, Research Resources

Biological Carcinogenesis Branch, DCE, NCI,
NIH

Executive Plaza North, Room 540

6130 Executive Blvd.

Bethesda, MD 20892

 

Chief, Environmental Epidemiology Branch,
DCE, NCI, NIH

Executive Plaza North, Room 443

6130 Executive Blvd.

Bethesda, MD 20892

 

Associate Director, Surveillance Program,
DCPC, NCI, NIH

Executive Plaza North, Room 343K

6130 Executive Blvd.

Bethesda, MD 20892

 

Head, Biostatistics and Data Management
Section, DCT, NCI, NIH

8601 Old Georgetown Road

Bethesda, MD 20892

 

Chief, Clinical Research Branch

Biological Response Modifiers Program

Frederick Cancer Research and Development
Center, DCT, NCI, NIH

501 W, 7th Street, Suite #3

 

14

 

Frederick, MD 21701

 

Deputy Branch Chief, Navy Hospital

NCI—Naval Medical Oncology Branch, DCT, NCI, NIH

Building 8, Room 5101

Bethesda, MD 20814

 

Chief, Pharmaceutical Management Branch

Cancer Therapy Evaluation Program, DCT, NCI, NIH

Executive Plaza North, Suite 804

Bethesda, MD 20892

 

Director, Extramural Clinical Studies, BRB,
BRMP, DCT, NCI, NIH

Frederick Cancer Research and Development Center

Fort Detrick

Frederick, MD 21701

 

National Eye Institute

Clinical Director, NEI, NIH

Building 10, Room 10N-202

10 Center Drive

Bethesda, MD 20892

 

Director, Division of Biometry and
Epidemiology, NEI, NIH

Building 31, Room 6A-52

31 Center Drive

Bethesda, MD 20892

National Heart Lung and Blood Institute

Administrative Officer, Division of
Intramural Research, NHLBI, NIH

Building 10 Room 7N220

10 Center Drive, MSC 1670

Bethesda, MD 20892-1670

 

Senior Scientific Advisor, OD

Division of Epidemiology and Clinical Applications, NHLBI, NIH

Federal Building, 220

7550 Wisconsin Avenue

Bethesda, MD 20892

 

National Institute on Aging

Computer Scientist, Longitudinal Studies
Branch, IRP, NIH

Gerontology Research Center, GRC

4940 Eastern Avenue

Baltimore, MD 21224

 

Associate Director, Epidemiology,

Demography and Biometry Program, NIA, NIH

Gateway Building, Suite 3C309

7201 Wisconsin Avenue

Bethesda, MD 20892

 

National Institute on Alcohol Abuse and
Alcoholism

 

15

 

Deputy Director, Division of Biometry and
Epidemiology, NIAAA, NIH

Willco Building, Suite 514

6000 Executive Blvd., MSC 7003

Bethesda, MD 20892-7003

 

Deputy Director, Div. of Clinical and
Prevention Res., NIAAA, NIH

Willco Building, Suite 505

6000 Executive Blvd., MSC 7003

Bethesda, MD 20892-7003

 

National Institute of Allergy and Infectious
Diseases

Chief, Respiratory Viruses Section, LID,
NIAID, NIH

Building 7, Room 106

9000 Rockville Pike

Bethesda, MD 20892

 

Chief, Hepatitis Virus Section, LID, NIAID,
NIH

Building 7, Room 202

9000 Rockville Pike

Bethesda, MD 20892

 

Chief, Epidemology and Biometry Branch, DMID,
NIAID, NIH

Solar Building, Room 3A24

Bethesda, Maryland 20892

 

Special Assistant, Clinical Research Program,
DAIDS, NIAID, NIH

Solar Building, Room 2C-20

6003 Executive Blvd.

Bethesda, MD 20892

 

National Institute of Arthritis and
Musculoskeletal and Skin Diseases

Clinical Director, NIAMS, NIH

Building 10, Room 9S205

10 Center Drive

Bethesda, MD 20892

 

National Institute of Child Health and Human
Development

Chief, Contracts Management Branch, NICHD,
NIH

Executive Plaza North, Room 7A07

6100 Executive Blvd.

North Bethesda, MD 20892

 

National Institute on Deafness and Other
Communication Disorders

Acting Director of Intramural Research,
NIDCD, NIH

Building 31, Room 3C02

31 Center Drive

Bethesda, MD 20892

 

Director, Division of Human Communication,
NIDCD, NIH

Executive Plaza South, Room 400B

 

16

 

6120 Executive Boulevard

Rockville, MD 20852

 

National Institute of Dental Research

Deputy Clinical Director, NIDR, NIH

Building 10, Room 1N-113

10 Center Drive, MSC 1190

Bethesda, MD 20892-1190

 

Research Psychologist, Clinical
Invsetigations, NIDR, NIH

Building 10, Room 1N114

10 Center Drive, MSC 1190

Bethesda, MD 20892-1190

 

Chief, Contract Management Section

Extramural Program, NIDR, NIH

Natcher Building, Room 4AN-44B

45 Center Drive, MSC 6402

Bethesda, MD 20892-6402

 

National Institute of Diabetes and Digestive
and Kidney Diseases

Chief, Clinical Investigations, NIDDK, NIH

Building 10, Room 9N222

10 Center Drive

Bethesda, MD 20892

 

Chief, Phoenix Clinical Research Section,
NIDDK, NIH

Phoenix Area Indian Hospital, Room 541

4212 North 16th Street

Phoenix, Arizona 85016

 

Chief, Diabetes Research Section, DPB, DDEMD,
NIDDK, NIH

Natcher Building, Room 5AN-18G

45 Center Drive, MSC 6600

Bethesda, MD 20892

 

National Institute on Drug Abuse

Privacy Act Coordinator, NIDA, NIH

Parklawn Building, Room 10A-42

5600 Fishers Lane

Rockville, Maryland 20857

 

National Institute of Environmental Health
Sciences

Chief, Epidemiology Branch, NIEHS, NIH

P.O. Box 12233

Research Triangle Park

North Carolina 27709

 

National Institute of Mental Health

Director, Intramural Research Program, NIMH,
NIH

Building 10, Room 4N-224

9000 Rockville Pike

Bethesda, MD 20205

 

17

 

Privacy Act Coordinator, NIMH, NIH

Parklawn Building, Room 7C22

5600 Fishers Lane

Rockville, Maryland 20857

 

Clinical Director, Neuroscience Research
Center, DIRP, NIMH

Saint Elizabeths Hospital,

William A. White Building, Room 133

2700 Martin Luther King Jr., Avenue, SE

Washington, DC 20032

 

National Institute of Neurological Disorders
and Stroke

 

[[Page 16602]]

 

Chief, Epilepsy Branch, NINDS, NIH

Federal Building, Room 114

7750 Wisconsin Avenue

Bethesda, MD 20892

 

Chief, Development Neurology Branch, NINDS,
NIH

Federal Building, NIH

7550 Wisconsin Avenue

Bethesda, MD 20892

 

Assistant Director, CNP, DIR, NINDS, NIH

Building 10, Room 5N226

10 Center Drive

Bethesda, MD 20892

 

Deputy Chief, Laboratory of Central Nervous
Systems Studies

Intramural Research Program, NINDS, NIH

Building 36, Room 5B21,

9000 Rockville Pike

Bethesda, MD 20892

 

Director, Division of Fundamental
Neurosciences, NINDS, NIH

Federal Building, Room 916

7550 Wisconsin Ave

Bethesda, MD 20892

 

Director, Division of Convulsive,
Developmental and Neuromuscular Disorders, NINDS, NIH

Federal Building, Room 816

7550 Wisconsin Avenue

Bethesda, MD 20892

 

Director, Division of Demyelinating Atrophic,
and Dementing Disorders, NINDS, NIH

Federal Building, Room 810

7550 Wisconsin Avenue

Bethesda, MD 20892

 

18

 

Director, Division of Stroke and Trauma,
NINDS, NIH

Federal Building, Room 8A08

7550 Wisconsin Avenue

Bethesda, MD 20892

 

National Center for Human Genome Research

Chief, Office of Human Genome Communications,
NCHGR, NIH

Building 38A, Room 617

9000 Rockville Pike

Bethesda, MD 20892

 

[FR Doc. 97-8592 Filed 4-4-97; 8:45 am]

BILLING CODE 4140-01-M

 

19

 

HHSAR 352-223-70 SAFETY AND HEALTH (JANUARY 2001)

 

(a)               To help ensure the protection of the life
and health of all persons, and to help prevent damage to property, the
Contractor shall comply with all Federal, State and local laws and regulations
applicable to the work being performed under this contract.  These laws are implemented and/or enforced
by the Environmental Protection Agency, Occupational Safety and Health
Administration and other agencies at the Federal, State and local levels
(Federal, State and local regulatory/enforcement agencies).

 

(b)              Further, the Contractor shall take or
cause to be taken additional safety measures as the Contracting Officer in
conjunction with the project or other appropriate officer, determines to be
reasonably necessary.  If compliance
with these additional safety measures results in an increase or decrease in the
cost or time required for performance of any part of work under this contract,
an equitable adjustment will be made in accordance with the applicable
“Changes” Clause set forth in this contract.

 

(c)               The Contractor shall maintain an
accurate record of, and promptly report to the Contracting Officer, all
accidents or incidents resulting in the exposure of persons to toxic
substances, hazardous materials or hazardous operations; the injury or death of
any person; and/or damage to property incidental to work performed under the
contract and all violations for which the Contractor has been cited by
any Federal, State or local regulatory/enforcement agency.  The report shall include a copy of the
notice of violation and the findings of any inquiry or inspection, and an
analysis addressing the impact these violations may have on the work remaining
to be performed.  The report shall also
state the required action(s), if any, to be taken to correct any violation(s)
noted by the Federal, State or local regulatory/enforcement agency and the time
frame allowed by the agency to accomplish the necessary corrective action.

 

(d)              If the Contractor fails or refuses to
comply promptly with the Federal, State or local regulatory/enforcement
agency’s directive(s) regarding any violation(s) and prescribed corrective
action(s), the Contracting Officer may issue an order stopping all or part of
the work until satisfactory corrective action (as approved by the Federal,
State or local regulatory/enforcement agencies) has been taken and documented
to the Contracting Officer.  No part of
the time lost due to any stop work order shall be subject to a claim for
extension of time or costs or damages by the Contractor.

 

(e)               The Contractor shall insert the
substance of this clause in each subcontract involving toxic substances,
hazardous materials, or operations. Compliance with the provisions of this
clause by subcontractors will be the responsibility of the Contractor.

 

(End of clause)

 

 

PROCUREMENT OF CERTAIN EQUIPMENT

 

Notwithstanding any other clause in this contract, the Contractor will
not be reimbursed for the purchase, lease, or rental of any item of equipment
listed in the following Federal Supply Groups, regardless of the dollar value,
without the prior written approval of the Contracting Officer.

 

	
  67 -

  	
   

  	
  Phonographic Equipment

  
	
  69 -

  	
   

  	
  Training Aids and Devices

  
	
  70 -

  	
   

  	
  General Purpose ADP Equipment, Software, Supplies and Support
  (Excluding 7045-ADP Supplies and Support Equipment.)

  
	
  71 -

  	
   

  	
  Furniture

  
	
  72 -

  	
   

  	
  Household and Commercial Furnishings and Appliances

  
	
  74 -

  	
   

  	
  Office Machines and Visible Record Equipment

  
	
  77 -

  	
   

  	
  Musical Instruments, Phonographs, and Home-type Radios

  
	
  78 -

  	
   

  	
  Recreational and Athletic Equipment

  

 

When equipment in these Federal Supply Groups is requested by the Contractor
and determined essential by the Contracting Officer, the Government will
endeavor to fulfill the requirement with equipment available from its excess
personal property sources, provided the request is made under a contract.  Extensions or renewals of approved existing
leases or rentals for equipment in these Federal Supply Groups are excluded
from the provisions of this article.

 

	
  NIH(RC)-7 (4/1/84)

  	
   

  	
   

  	
   

  	
   

  
	
  OMB Bulletin 81-16

  	
   

  	
   

  	
   

  	
  ATTACHMENT 8

  

 

 

SCHEDULE I-B

 

	
  ITEM

  	
   

  	
  QUANTITY

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  LN2 Freezer, XLC-1830

  	
   

  	
  10

  	
   

  	
   

  
	
  Racking System for LN2’s

  	
   

  	
  10

  	
   

  	
   

  
	
  Additional LN2 Vacuum Piping

  	
   

  	
  1

  	
   

  	
   

  
	
  -70oC So-Low Chest Freezers

  	
   

  	
  75

  	
   

  	
   

  
	
  Racking System for -70oC’s

  	
   

  	
  75

  	
   

  	
   

  
	
  Controlled Rate Freezer

  	
   

  	
  1

  	
   

  	
   

  
	
  Bar Coding Scanner

  	
   

  	
  1

  	
   

  	
   

  
	
  Computers

  	
   

  	
  5

  	
   

  	
   

  
	
  Cryo-Shipper

  	
   

  	
  5

  	
   

  	
   

  
	
  Flammable Storage Unit

  	
   

  	
  1

  	
   

  	
   

  
	
  Slide Storage Cabinet

  	
   

  	
  1

  	
   

  	
   

  

 

 

Government Property Schedule 11-A

 

“Laboratory
Support for Processing and Storage of Biological Specimens”

 

	
  Job#

  	
   

  	
  Item #

  	
   

  	
  Piece#

  	
   

  	
  Description

  	
   

  	
  Gfp or

  Cap

  	
   

  	
  Class

  	
   

  	
  Mfr

  	
   

  	
  Model

  	
   

  	
  Serial No

  	
   

  	
  Cost

  	
   

  	
  Gov ID

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  051

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  1,780

  	
   

  	
  01029103

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  053

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  1,780

  	
   

  	
  01029102

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  055

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  1,780

  	
   

  	
  01029104

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  056

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,680

  	
   

  	
  01029124

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  057

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,539

  	
   

  	
  01029117

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  058

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,850

  	
   

  	
  01029105

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  059

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,729

  	
   

  	
  01029129

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  060

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,539

  	
   

  	
  01029118

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  061

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  69929-77

  	
   

  	
  $

  	
  4,539

  	
   

  	
  01029116

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  062

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,850

  	
   

  	
  01029106

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  063

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  60091-118

  	
   

  	
  $

  	
  4,539

  	
   

  	
  01029119

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  064

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  60091-119

  	
   

  	
  $

  	
  4,539

  	
   

  	
  01029120

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  066

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,732

  	
   

  	
  01029121

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  067

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,680

  	
   

  	
  01029123

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  068

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,680

  	
   

  	
  01029125

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  069

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  11611-479

  	
   

  	
  $

  	
  4,680

  	
   

  	
  01029126

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  070

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,275

  	
   

  	
  01029127

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  071

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,275

  	
   

  	
  01029128

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  072

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,857

  	
   

  	
  01029130

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  073

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,857

  	
   

  	
  01029131

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  074

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,857

  	
   

  	
  01029132

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  075

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  13029-220

  	
   

  	
  $

  	
  4,743

  	
   

  	
  01029133

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  076

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,743

  	
   

  	
  01029134

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  077

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,743

  	
   

  	
  01029135

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  078

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  13071-255

  	
   

  	
  $

  	
  4,743

  	
   

  	
  01029136

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  079

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  SE27,120

  	
   

  	
  13071-256

  	
   

  	
  $

  	
  4,503

  	
   

  	
  1023092

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  080

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  5,028

  	
   

  	
  1029137

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  081

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  5,028

  	
   

  	
  1029138

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  082

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  SE27,120

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,053

  	
   

  	
  1023091

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  083

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,473

  	
   

  	
  00811080

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  084

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  4,473

  	
   

  	
  00811081

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  085

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  5,431

  	
   

  	
  00811940

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  086

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  5,431

  	
   

  	
  00811941

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  087

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  SE27,120

  	
   

  	
  ????

  	
   

  	
  $

  	
  5,243

  	
   

  	
  00871523

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  088

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  SE27,120

  	
   

  	
  ????

  	
   

  	
  $

  	
  5,243

  	
   

  	
  00871522

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  089

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  6,748

  	
   

  	
  01175129

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  090

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  6,748

  	
   

  	
  01175130

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  091

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  7,050

  	
   

  	
  01096558

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  092

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  FORMA

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  7,050

  	
   

  	
  01096559

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  093

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  C15-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  8,792

  	
   

  	
  01182917

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  094

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  C15-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  10,080

  	
   

  	
  01190561

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  095

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  C15-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  9,318

  	
   

  	
  01190562

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  096

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  C15-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  9,318

  	
   

  	
  01190563

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  048

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  C15-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  8,993

  	
   

  	
  01264713

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  047

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  C15-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  8,993

  	
   

  	
  01264714

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  045

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  ???-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  9,268

  	
   

  	
  01250392

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  046

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  ???-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  9,268

  	
   

  	
  01250393

  

 

1

 

	
  129

  	
   

  	
  OMF

  	
   

  	
  043

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  ????-27

  	
   

  	
  9697237

  	
   

  	
  $

  	
  9,808

  	
   

  	
  01213988

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  044

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  ????-27

  	
   

  	
  9697236

  	
   

  	
  $

  	
  9,808

  	
   

  	
  01213989

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  Mbu1

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  ????-27

  	
   

  	
  9697420

  	
   

  	
  $

  	
  5,525

  	
   

  	
  01264570

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  Mbu2

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  ????-27

  	
   

  	
  9697421

  	
   

  	
  $

  	
  5,525

  	
   

  	
  01264571

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  #Mbu3

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  ????-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  5,525

  	
   

  	
  01264572

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  #Mbu4

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  ????-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  5,525

  	
   

  	
  01264573

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  #Mbu5

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  ????-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  5,525

  	
   

  	
  01264574

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  #Mbu6

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  ????-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  5,525

  	
   

  	
  01264575

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  #Mbu7

  	
   

  	
  Mechanical Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  SOLOW

  	
   

  	
  ????-27

  	
   

  	
  ????

  	
   

  	
  $

  	
  5,525

  	
   

  	
  01264576

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M1A

  	
   

  	
  Cntrl Rare Frz-Prog

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  9,870

  	
   

  	
  01029113

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M1B

  	
   

  	
  CRF-Chamber

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
   

  	
   

  	
  01029113

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M2A

  	
   

  	
  Cntrl Rare-Controller

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  1010

  	
   

  	
  ????

  	
   

  	
  $

  	
  10,754

  	
   

  	
  01029157

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M2B

  	
   

  	
  CRF-Recorder

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
   

  	
   

  	
  01029157

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M2C

  	
   

  	
  CRF-Chamber

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
   

  	
   

  	
  01029157

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M3

  	
   

  	
  LN2 Tank

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  1,295

  	
   

  	
  1029156

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M4

  	
   

  	
  LN2 Dry Shipper

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  CMD-20

  	
   

  	
  CMD-20-1

  	
   

  	
  $

  	
  1,100

  	
   

  	
  1029156

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M5

  	
   

  	
  Laminar Flow Hood

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  1,182

  	
   

  	
   

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M6

  	
   

  	
  Laminar Flow Hood

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  CCI

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  8,952

  	
   

  	
   

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M7

  	
   

  	
  Refrigerator

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  880

  	
   

  	
   

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M8

  	
   

  	
  Water Bath

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  450

  	
   

  	
   

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M10

  	
   

  	
  Hood, BioSafety

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  3,860

  	
   

  	
   

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M11

  	
   

  	
  Freezer, Vertical

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  580

  	
   

  	
   

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M12

  	
   

  	
  Freezer, Vertical

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  580

  	
   

  	
   

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M13

  	
   

  	
  Microscope

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  11,956

  	
   

  	
   

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M14

  	
   

  	
  Generator

  	
   

  	
  CAP

  	
   

  	
  Over

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  40,300

  	
   

  	
   

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M15

  	
   

  	
  Walk-in Refrigerator

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  7,776

  	
   

  	
   

  
	
  129

  	
   

  	
  OMF

  	
   

  	
  M16

  	
   

  	
  Walk-in Freezer

  	
   

  	
  CAP

  	
   

  	
  Under

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  ????

  	
   

  	
  $

  	
  9,250

  	
   

  	
   

  

 

2

 

GOVERNMENT PROPERTY - SCHEDULE

 

	
   

  	
   

  	
   

  
	
  CONTRACTOR:

  	
   

  	
  CONTRACT NUMBER

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  ADDRESS

  	
   

  	
  REPORT DATE:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  FISCAL YEAR:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  SIGNED BY:

  	
   

  	
  DATE SIGNED:

  
				

 

 

Report of Government Owned, Contractor Held Property

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}]]